Pathway.name,Unique.genes,Phosphoproteomics,PhosphoproteomicsFDR_BH,Proteomics,ProteomicsFDR_BH,Transcriptomics,TranscriptomicsFDR_BH,Combined,CombinedFDR_BH,Contrast
Protein processing in endoplasmic reticulum,157,0.021878911,0.662931,0.795957262,1.00E+00,1.56E-08,0.00000536,0.001771549,0.20254705,X1O2NoCyA - X1O2PlusCyA
Intestinal immune network for IgA production,35,0.522552184,1,0.019377865,5.47E-01,0.000275229,0.031467831,0.004194206,0.30118734,X1O2NoCyA - X1O2PlusCyA
Systemic lupus erythematosus,96,0.435137004,1,0.303091955,1.00E+00,0.0000246,0.004217462,0.022455962,0.85582165,X1O2NoCyA - X1O2PlusCyA
Malaria,24,NA,NA,0.001556096,1.76E-01,0.033494617,0.547078739,0.000253298,0.08688106,X1O2NoCyA - X1O2PlusCyA
Complement and coagulation cascades,36,1,1,9.33E-06,3.16E-03,0.964592095,1,0.981518113,1,X1O2NoCyA - X1O2PlusCyA
N-Glycan biosynthesis,47,0.056016816,0.707634,0.265999827,1.00E+00,0.00116419,0.057045326,0.004390486,0.30118734,X1O2NoCyA - X1O2PlusCyA
Asthma,19,0.043506396,0.707634,0.015713304,5.33E-01,0.033420799,0.547078739,0.000629093,0.10788943,X1O2NoCyA - X1O2PlusCyA
Staphylococcus aureus infection,38,0.556137169,1,0.000348167,5.90E-02,0.163167619,0.861022976,0.006423511,0.3672107,X1O2NoCyA - X1O2PlusCyA
Allograft rejection,28,0.742058018,1,0.030268985,6.41E-01,0.003792212,0.144525411,0.034265137,0.97941183,X1O2NoCyA - X1O2PlusCyA
Various types of N-glycan biosynthesis,34,0.056016816,0.707634,0.219626241,1.00E+00,0.011494136,0.312361595,0.007762615,0.38036813,X1O2NoCyA - X1O2PlusCyA
ECM-receptor interaction,43,1,1,0.003471217,1.97E-01,0.041671398,0.621447369,0.959942285,1,X1O2NoCyA - X1O2PlusCyA
Viral myocarditis,51,0.432645749,1,0.007546052,3.06E-01,0.049340995,0.633911248,0.010018944,0.42956224,X1O2NoCyA - X1O2PlusCyA
Cell adhesion molecules,81,0.568852976,1,0.054287666,8.76E-01,0.005228994,0.179354508,0.027768609,0.94308,X1O2NoCyA - X1O2PlusCyA
Autoimmune thyroid disease,28,0.742058018,1,0.072121844,1.00E+00,0.003792212,0.144525411,0.060467184,1,X1O2NoCyA - X1O2PlusCyA
Glycerophospholipid metabolism,66,0.933894866,1,0.003491869,1.97E-01,0.068217829,0.72644861,0.09032288,1,X1O2NoCyA - X1O2PlusCyA
Oocyte meiosis,108,0.000363159,0.1100373,0.915303414,1.00E+00,0.854922387,1,0.179949371,1,X1O2NoCyA - X1O2PlusCyA
Alcoholism,140,0.532164251,1,0.882347892,1.00E+00,0.000627193,0.053781841,0.337651495,1,X1O2NoCyA - X1O2PlusCyA
Biosynthesis of unsaturated fatty acids,22,1,1,0.372653957,1.00E+00,0.000876461,0.057045326,0.997057671,1,X1O2NoCyA - X1O2PlusCyA
Graft-versus-host disease,29,0.742058018,1,0.030268985,6.41E-01,0.016622466,0.380100379,0.053354862,1,X1O2NoCyA - X1O2PlusCyA
Type I diabetes mellitus,31,0.803442221,1,0.046005073,7.81E-01,0.011838778,0.312361595,0.079882373,1,X1O2NoCyA - X1O2PlusCyA
Long-term depression,43,0.038904155,0.707634,0.97018726,1.00E+00,0.023172585,0.441566473,0.241928319,1,X1O2NoCyA - X1O2PlusCyA
Viral carcinogenesis,179,0.971415095,1,0.925341919,1.00E+00,0.001084404,0.057045326,0.841954854,1,X1O2NoCyA - X1O2PlusCyA
PI3K-Akt signaling pathway,223,0.402570744,1,0.284273798,1.00E+00,0.009029227,0.281547701,0.074542604,1,X1O2NoCyA - X1O2PlusCyA
Toxoplasmosis,94,0.922585407,1,0.002376115,1.97E-01,0.493538479,1,0.182110717,1,X1O2NoCyA - X1O2PlusCyA
Hippo signaling pathway - multiple species,21,0.012610811,0.6385429,0.394299957,1.00E+00,0.270139026,1,0.030244548,0.94308,X1O2NoCyA - X1O2PlusCyA
Long-term potentiation,52,0.007011238,0.6385429,0.641478037,1.00E+00,0.314233127,1,0.059197302,1,X1O2NoCyA - X1O2PlusCyA
Glycerolipid metabolism,44,1,1,0.008126815,3.06E-01,0.179848554,0.900072234,0.987987032,1,X1O2NoCyA - X1O2PlusCyA
Signaling pathways regulating pluripotency of stem cells,99,0.694513782,1,0.025757316,6.24E-01,0.08708768,0.72644861,0.072887243,1,X1O2NoCyA - X1O2PlusCyA
Vitamin digestion and absorption,12,0.556137169,1,0.07643009,1.00E+00,0.046975175,0.633911248,0.069298365,1,X1O2NoCyA - X1O2PlusCyA
GnRH signaling pathway,74,0.005300025,0.6385429,0.641478037,1.00E+00,0.863228302,1,0.154269879,1,X1O2NoCyA - X1O2PlusCyA
Arrhythmogenic right ventricular cardiomyopathy,40,1,1,0.00501418,2.43E-01,0.659849467,1,0.9960546,1,X1O2NoCyA - X1O2PlusCyA
Rheumatoid arthritis,63,0.239774671,1,0.061658651,9.50E-01,0.248823115,1,0.042207706,1,X1O2NoCyA - X1O2PlusCyA
Terpenoid backbone biosynthesis,21,0.043506396,0.707634,0.372653957,1.00E+00,0.270139026,1,0.058347564,1,X1O2NoCyA - X1O2PlusCyA
Sulfur relay system,8,1,1,0.046071697,7.81E-01,0.103037218,0.763224992,0.995193724,1,X1O2NoCyA - X1O2PlusCyA
Cholinergic synapse,73,0.063056494,0.707634,0.297429645,1.00E+00,0.27832125,1,0.057672915,1,X1O2NoCyA - X1O2PlusCyA
TNF signaling pathway,84,0.600728786,1,0.040575685,7.81E-01,0.225257331,1,0.104544925,1,X1O2NoCyA - X1O2PlusCyA
Estrogen signaling pathway,84,0.013006614,0.6385429,0.912259236,1.00E+00,0.47488792,1,0.273039971,1,X1O2NoCyA - X1O2PlusCyA
Cholesterol metabolism,33,0.089849775,0.9009927,0.070043172,1.00E+00,0.913971309,1,0.094774294,1,X1O2NoCyA - X1O2PlusCyA
Fatty acid elongation,21,1,1,0.372653957,1.00E+00,0.016330985,0.380100379,0.999145403,1,X1O2NoCyA - X1O2PlusCyA
Oxytocin signaling pathway,110,0.138677051,1,0.172426636,1.00E+00,0.273217043,1,0.059618717,1,X1O2NoCyA - X1O2PlusCyA
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,15,NA,NA,0.220229008,1.00E+00,0.131262604,0.789222628,0.108409911,1,X1O2NoCyA - X1O2PlusCyA
SNARE interactions in vesicular transport,33,0.058634121,0.707634,0.308500741,1.00E+00,0.404826404,1,0.07430422,1,X1O2NoCyA - X1O2PlusCyA
Small cell lung cancer,75,0.970885887,1,0.370952679,1.00E+00,0.020500163,0.413620928,0.595088411,1,X1O2NoCyA - X1O2PlusCyA
alpha-Linolenic acid metabolism,11,NA,NA,1,1.00E+00,0.029389322,0.530554601,0.999996722,1,X1O2NoCyA - X1O2PlusCyA
Fat digestion and absorption,21,NA,NA,0.158742587,1.00E+00,0.189702248,0.903720431,0.095407597,1,X1O2NoCyA - X1O2PlusCyA
Hippo signaling pathway,118,0.2914626,1,0.084820319,1.00E+00,0.313344172,1,0.075027149,1,X1O2NoCyA - X1O2PlusCyA
Neutrophil extracellular trap formation,138,0.564165208,1,0.761913281,1.00E+00,0.018167474,0.389465231,0.406111078,1,X1O2NoCyA - X1O2PlusCyA
AMPK signaling pathway,97,0.274303728,1,0.623154117,1.00E+00,0.045966048,0.633911248,0.200855375,1,X1O2NoCyA - X1O2PlusCyA
Focal adhesion,139,0.88996699,1,0.079550395,1.00E+00,0.113482433,0.763224992,0.282320614,1,X1O2NoCyA - X1O2PlusCyA
Leishmaniasis,59,0.775925061,1,0.021653718,5.65E-01,0.52675407,1,0.214948298,1,X1O2NoCyA - X1O2PlusCyA
Thyroid hormone synthesis,50,0.14148759,1,0.506274882,1.00E+00,0.124078116,0.78125405,0.127463887,1,X1O2NoCyA - X1O2PlusCyA
Nucleotide excision repair,46,0.014751815,0.6385429,0.73901397,1.00E+00,0.817792552,1,0.254058055,1,X1O2NoCyA - X1O2PlusCyA
Proximal tubule bicarbonate reclamation,16,0.056016816,0.707634,0.554756722,1.00E+00,0.287600405,1,0.121359299,1,X1O2NoCyA - X1O2PlusCyA
Linoleic acid metabolism,9,NA,NA,NA,NA,0.151138535,0.83671924,0.151138535,1,X1O2NoCyA - X1O2PlusCyA
Pancreatic secretion,56,0.014751815,0.6385429,0.910320847,1.00E+00,0.684922592,1,0.355906002,1,X1O2NoCyA - X1O2PlusCyA
Serotonergic synapse,65,0.058634121,0.707634,0.834378721,1.00E+00,0.203494836,0.940991365,0.237249453,1,X1O2NoCyA - X1O2PlusCyA
Sphingolipid signaling pathway,99,0.019680359,0.662931,0.669113178,1.00E+00,0.769451717,1,0.216890842,1,X1O2NoCyA - X1O2PlusCyA
Glycosaminoglycan biosynthesis - heparan sulfate / heparin,14,NA,NA,0.39202277,1.00E+00,0.098019901,0.7499563,0.185340176,1,X1O2NoCyA - X1O2PlusCyA
Inflammatory bowel disease,41,0.803442221,1,0.019147545,5.47E-01,0.659849467,1,0.265327094,1,X1O2NoCyA - X1O2PlusCyA
Salivary secretion,55,0.02137329,0.662931,0.850391757,1.00E+00,0.599497814,1,0.288769715,1,X1O2NoCyA - X1O2PlusCyA
Sphingolipid metabolism,38,0.141640534,1,0.449648589,1.00E+00,0.188875702,0.903720431,0.130219353,1,X1O2NoCyA - X1O2PlusCyA
Longevity regulating pathway,73,0.590795313,1,0.430120492,1.00E+00,0.049899719,0.633911248,0.275000262,1,X1O2NoCyA - X1O2PlusCyA
Cushing syndrome,110,0.473282536,1,0.218641903,1.00E+00,0.125273973,0.78125405,0.160835195,1,X1O2NoCyA - X1O2PlusCyA
Cysteine and methionine metabolism,42,0.216599053,1,0.792585547,1.00E+00,0.075696154,0.72644861,0.295720769,1,X1O2NoCyA - X1O2PlusCyA
Calcium signaling pathway,129,0.173354104,1,0.132803968,1.00E+00,0.593030295,1,0.10577712,1,X1O2NoCyA - X1O2PlusCyA
Mucin type O-glycan biosynthesis,20,NA,NA,0.124029751,1.00E+00,0.449912908,1,0.145090172,1,X1O2NoCyA - X1O2PlusCyA
Circadian entrainment,60,0.058634121,0.707634,0.551641673,1.00E+00,0.496692531,1,0.172138793,1,X1O2NoCyA - X1O2PlusCyA
Dopaminergic synapse,93,0.062920166,0.707634,0.48200273,1.00E+00,0.544225738,1,0.161079239,1,X1O2NoCyA - X1O2PlusCyA
Platelet activation,90,0.028519305,0.707634,0.713164622,1.00E+00,0.857347701,1,0.318966087,1,X1O2NoCyA - X1O2PlusCyA
Hematopoietic cell lineage,53,0.362788475,1,0.118645572,1.00E+00,0.405193772,1,0.137832851,1,X1O2NoCyA - X1O2PlusCyA
Glutamatergic synapse,74,0.058634121,0.707634,0.924838208,1.00E+00,0.32606258,1,0.395019147,1,X1O2NoCyA - X1O2PlusCyA
Fluid shear stress and atherosclerosis,96,0.139534596,1,0.151324573,1.00E+00,0.885436087,1,0.179860699,1,X1O2NoCyA - X1O2PlusCyA
Gastric acid secretion,46,0.038904155,0.707634,0.850391757,1.00E+00,0.583942393,1,0.34449157,1,X1O2NoCyA - X1O2PlusCyA
Bile secretion,34,0.148899796,1,0.372653957,1.00E+00,0.365934738,1,0.152558391,1,X1O2NoCyA - X1O2PlusCyA
Fc epsilon RI signaling pathway,53,0.062920166,0.707634,0.61335338,1.00E+00,0.52675407,1,0.214601926,1,X1O2NoCyA - X1O2PlusCyA
B cell receptor signaling pathway,74,0.166946101,1,0.546170938,1.00E+00,0.236645086,1,0.202036191,1,X1O2NoCyA - X1O2PlusCyA
Folate biosynthesis,15,1,1,0.316289724,1.00E+00,0.068241138,0.72644861,0.999492489,1,X1O2NoCyA - X1O2PlusCyA
Antigen processing and presentation,55,0.432645749,1,0.792585547,1.00E+00,0.069875933,0.72644861,0.440235325,1,X1O2NoCyA - X1O2PlusCyA
Insulin signaling pathway,114,0.681740792,1,0.466907789,1.00E+00,0.076292739,0.72644861,0.383960969,1,X1O2NoCyA - X1O2PlusCyA
Th17 cell differentiation,89,0.377857224,1,0.221295823,1.00E+00,0.307693556,1,0.185079779,1,X1O2NoCyA - X1O2PlusCyA
Synthesis and degradation of ketone bodies,7,0.23699422,1,0.478311484,1.00E+00,0.227305106,1,0.213965609,1,X1O2NoCyA - X1O2PlusCyA
Transcriptional misregulation in cancer,126,0.874573223,1,0.739439898,1.00E+00,0.040471022,0.621447369,0.690516676,1,X1O2NoCyA - X1O2PlusCyA
FoxO signaling pathway,107,0.124525082,1,0.738272558,1.00E+00,0.293212433,1,0.290885752,1,X1O2NoCyA - X1O2PlusCyA
Aldosterone synthesis and secretion,62,0.371970426,1,0.169029502,1.00E+00,0.433990096,1,0.183955034,1,X1O2NoCyA - X1O2PlusCyA
Adrenergic signaling in cardiomyocytes,93,0.193774987,1,0.382972998,1.00E+00,0.375165901,1,0.188786976,1,X1O2NoCyA - X1O2PlusCyA
Ubiquitin mediated proteolysis,131,0.061600153,0.707634,0.503270153,1.00E+00,0.93113143,1,0.332307909,1,X1O2NoCyA - X1O2PlusCyA
T cell receptor signaling pathway,79,0.422325163,1,0.084820319,1.00E+00,0.806770049,1,0.246075911,1,X1O2NoCyA - X1O2PlusCyA
Peroxisome,70,0.339724601,1,0.48200273,1.00E+00,0.181064094,0.900072234,0.2574534,1,X1O2NoCyA - X1O2PlusCyA
Viral protein interaction with cytokine and cytokine receptor,30,0.417971624,1,0.825102122,1.00E+00,0.087140069,0.72644861,0.479359186,1,X1O2NoCyA - X1O2PlusCyA
Prostate cancer,73,0.221800684,1,0.430120492,1.00E+00,0.327189541,1,0.215041532,1,X1O2NoCyA - X1O2PlusCyA
PPAR signaling pathway,49,0.417971624,1,0.089716697,1.00E+00,0.855782057,1,0.274637353,1,X1O2NoCyA - X1O2PlusCyA
Progesterone-mediated oocyte maturation,81,0.03535009,0.707634,0.926737095,1.00E+00,0.988559579,1,0.737137596,1,X1O2NoCyA - X1O2PlusCyA
Neuroactive ligand-receptor interaction,108,0.803442221,1,0.046005073,7.81E-01,0.887501284,1,0.473230991,1,X1O2NoCyA - X1O2PlusCyA
Human papillomavirus infection,248,0.964353679,1,0.386637418,1.00E+00,0.088955092,0.72644861,0.683101908,1,X1O2NoCyA - X1O2PlusCyA
MAPK signaling pathway,205,0.656290338,1,0.127859146,1.00E+00,0.404830237,1,0.285288303,1,X1O2NoCyA - X1O2PlusCyA
Renal cell carcinoma,56,0.377857224,1,0.816015102,1.00E+00,0.110285097,0.763224992,0.463724216,1,X1O2NoCyA - X1O2PlusCyA
Arginine and proline metabolism,35,0.23699422,1,0.225153704,1.00E+00,0.638813301,1,0.205291414,1,X1O2NoCyA - X1O2PlusCyA
ABC transporters,29,1,1,0.394299957,1.00E+00,0.087140069,0.72644861,0.999742613,1,X1O2NoCyA - X1O2PlusCyA
Bladder cancer,33,0.289021513,1,0.778845847,1.00E+00,0.153024631,0.83671924,0.397476425,1,X1O2NoCyA - X1O2PlusCyA
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,25,1,1,0.124029751,1.00E+00,0.28117342,1,0.999305677,1,X1O2NoCyA - X1O2PlusCyA
Cortisol synthesis and secretion,39,0.435137004,1,0.265526545,1.00E+00,0.302366243,1,0.237836574,1,X1O2NoCyA - X1O2PlusCyA
Choline metabolism in cancer,72,0.694513782,1,0.19763981,1.00E+00,0.258259917,1,0.319708614,1,X1O2NoCyA - X1O2PlusCyA
Chemical carcinogenesis - receptor activation,123,0.124525082,1,0.587052487,1.00E+00,0.496266202,1,0.268816573,1,X1O2NoCyA - X1O2PlusCyA
Biosynthesis of cofactors,111,0.970885887,1,0.441913638,1.00E+00,0.091070817,0.72644861,0.736589012,1,X1O2NoCyA - X1O2PlusCyA
Steroid hormone biosynthesis,19,NA,NA,1,1.00E+00,0.121184337,0.78125405,0.999999457,1,X1O2NoCyA - X1O2PlusCyA
Cytokine-cytokine receptor interaction,113,0.775925061,1,0.630119987,1.00E+00,0.082214111,0.72644861,0.57044147,1,X1O2NoCyA - X1O2PlusCyA
Th1 and Th2 cell differentiation,75,0.770261184,1,0.19763981,1.00E+00,0.27832125,1,0.384527965,1,X1O2NoCyA - X1O2PlusCyA
Biosynthesis of amino acids,66,0.568852976,1,0.890402315,1.00E+00,0.08552093,0.72644861,0.649696782,1,X1O2NoCyA - X1O2PlusCyA
Influenza A,128,0.874781801,1,0.372409277,1.00E+00,0.137206265,0.79765676,0.548186863,1,X1O2NoCyA - X1O2PlusCyA
Arachidonic acid metabolism,25,0.417971624,1,0.394299957,1.00E+00,0.28117342,1,0.296994957,1,X1O2NoCyA - X1O2PlusCyA
Insulin resistance,88,0.719444614,1,0.19725065,1.00E+00,0.329698139,1,0.366256159,1,X1O2NoCyA - X1O2PlusCyA
2-Oxocarboxylic acid metabolism,17,NA,NA,0.176495459,1.00E+00,0.782911525,1,0.344583631,1,X1O2NoCyA - X1O2PlusCyA
JAK-STAT signaling pathway,86,0.27049006,1,0.195670388,1.00E+00,0.90559461,1,0.325858851,1,X1O2NoCyA - X1O2PlusCyA
Aminoacyl-tRNA biosynthesis,44,0.435222827,1,0.889493052,1.00E+00,0.124078116,0.78125405,0.596060543,1,X1O2NoCyA - X1O2PlusCyA
Human T-cell leukemia virus 1 infection,192,0.607401896,1,0.413722094,1.00E+00,0.194758896,0.91510002,0.384252195,1,X1O2NoCyA - X1O2PlusCyA
Protein digestion and absorption,42,0.803442221,1,0.622890151,1.00E+00,0.098390768,0.7499563,0.60489496,1,X1O2NoCyA - X1O2PlusCyA
Inflammatory mediator regulation of TRP channels,64,0.14148759,1,0.423080022,1.00E+00,0.837093883,1,0.325839728,1,X1O2NoCyA - X1O2PlusCyA
Fatty acid metabolism,50,1,1,0.856578132,1.00E+00,0.058993156,0.722666164,0.99998978,1,X1O2NoCyA - X1O2PlusCyA
Protein export,23,1,1,0.630119987,1.00E+00,0.080946124,0.72644861,0.999940306,1,X1O2NoCyA - X1O2PlusCyA
Renin secretion,38,0.089849775,0.9009927,0.875255465,1.00E+00,0.672695897,1,0.516231105,1,X1O2NoCyA - X1O2PlusCyA
Pancreatic cancer,69,0.547877851,1,0.621455486,1.00E+00,0.159044975,0.852381664,0.458273724,1,X1O2NoCyA - X1O2PlusCyA
Adherens junction,63,0.600728786,1,0.107672127,1.00E+00,0.843091642,1,0.401503984,1,X1O2NoCyA - X1O2PlusCyA
Mannose type O-glycan biosynthesis,19,NA,NA,0.220229008,1.00E+00,0.711033444,1,0.352078012,1,X1O2NoCyA - X1O2PlusCyA
TGF-beta signaling pathway,72,0.726548707,1,0.525038439,1.00E+00,0.146653038,0.83671924,0.512344548,1,X1O2NoCyA - X1O2PlusCyA
Natural killer cell mediated cytotoxicity,81,0.425851248,1,0.546170938,1.00E+00,0.242388141,1,0.375882006,1,X1O2NoCyA - X1O2PlusCyA
Parkinson disease,211,0.082138952,0.8888608,0.707256151,1.00E+00,0.999990732,1,0.862506329,1,X1O2NoCyA - X1O2PlusCyA
Cellular senescence,136,0.230265153,1,0.817374659,1.00E+00,0.314625262,1,0.467447661,1,X1O2NoCyA - X1O2PlusCyA
Endometrial cancer,52,0.547877851,1,0.165433206,1.00E+00,0.675252302,1,0.352845685,1,X1O2NoCyA - X1O2PlusCyA
Phospholipase D signaling pathway,102,0.249873161,1,0.48200273,1.00E+00,0.510523392,1,0.322186057,1,X1O2NoCyA - X1O2PlusCyA
NF-kappa B signaling pathway,79,0.804852106,1,0.251465417,1.00E+00,0.305146972,1,0.472813651,1,X1O2NoCyA - X1O2PlusCyA
mTOR signaling pathway,131,0.27729375,1,0.674207633,1.00E+00,0.332372355,1,0.397041822,1,X1O2NoCyA - X1O2PlusCyA
Gastric cancer,105,0.329986398,1,0.430120492,1.00E+00,0.43895351,1,0.322058171,1,X1O2NoCyA - X1O2PlusCyA
Vascular smooth muscle contraction,81,0.19489214,1,0.647252541,1.00E+00,0.506308587,1,0.377422293,1,X1O2NoCyA - X1O2PlusCyA
Vibrio cholerae infection,44,0.742058018,1,0.956425054,1.00E+00,0.090189698,0.72644861,0.846380419,1,X1O2NoCyA - X1O2PlusCyA
Ovarian steroidogenesis,24,1,1,0.316289724,1.00E+00,0.205756129,0.940991365,0.999802602,1,X1O2NoCyA - X1O2PlusCyA
Other types of O-glycan biosynthesis,35,1,1,0.24897577,1.00E+00,0.262223628,1,0.999753966,1,X1O2NoCyA - X1O2PlusCyA
Basal cell carcinoma,43,0.885951726,1,0.114347862,1.00E+00,0.678586449,1,0.574150498,1,X1O2NoCyA - X1O2PlusCyA
Butanoate metabolism,17,0.556137169,1,0.316608672,1.00E+00,0.395931358,1,0.374850886,1,X1O2NoCyA - X1O2PlusCyA
Hypertrophic cardiomyopathy,48,0.850257227,1,0.265526545,1.00E+00,0.31093854,1,0.533224885,1,X1O2NoCyA - X1O2PlusCyA
Cytosolic DNA-sensing pathway,41,0.668283531,1,0.137548136,1.00E+00,0.787553883,1,0.453735768,1,X1O2NoCyA - X1O2PlusCyA
Amphetamine addiction,48,0.435222827,1,0.308500741,1.00E+00,0.543168551,1,0.348274945,1,X1O2NoCyA - X1O2PlusCyA
Epstein-Barr virus infection,176,0.963388038,1,0.682880963,1.00E+00,0.111576167,0.763224992,0.844765965,1,X1O2NoCyA - X1O2PlusCyA
Necroptosis,125,0.265379121,1,0.561491233,1.00E+00,0.493692907,1,0.37580069,1,X1O2NoCyA - X1O2PlusCyA
Acute myeloid leukemia,56,0.625836359,1,0.227245578,1.00E+00,0.52675407,1,0.401445572,1,X1O2NoCyA - X1O2PlusCyA
Lipid and atherosclerosis,159,0.412093104,1,0.278234682,1.00E+00,0.653942114,1,0.353794211,1,X1O2NoCyA - X1O2PlusCyA
Ether lipid metabolism,27,1,1,1,1.00E+00,0.075278385,0.72644861,1,1,X1O2NoCyA - X1O2PlusCyA
Legionellosis,41,0.435222827,1,0.342668322,1.00E+00,0.514577081,1,0.360913473,1,X1O2NoCyA - X1O2PlusCyA
C-type lectin receptor signaling pathway,82,0.210309331,1,0.465013853,1.00E+00,0.806770049,1,0.400741224,1,X1O2NoCyA - X1O2PlusCyA
Colorectal cancer,77,0.481619788,1,0.449156299,1.00E+00,0.375624262,1,0.406982937,1,X1O2NoCyA - X1O2PlusCyA
"Valine, leucine and isoleucine degradation",42,0.141640534,1,0.798997735,1.00E+00,0.71995515,1,0.526045165,1,X1O2NoCyA - X1O2PlusCyA
GnRH secretion,41,0.148899796,1,0.793186123,1.00E+00,0.690809559,1,0.516069118,1,X1O2NoCyA - X1O2PlusCyA
Type II diabetes mellitus,29,0.148899796,1,0.897599905,1.00E+00,0.614809842,1,0.600029622,1,X1O2NoCyA - X1O2PlusCyA
Insulin secretion,49,0.289021513,1,0.916171075,1.00E+00,0.31093854,1,0.63365262,1,X1O2NoCyA - X1O2PlusCyA
Pathways of neurodegeneration - multiple diseases,380,0.111527234,1,0.741811714,1.00E+00,0.999998553,1,0.922858517,1,X1O2NoCyA - X1O2PlusCyA
Retinol metabolism,19,NA,NA,0.304547574,1.00E+00,0.711033444,1,0.4380027,1,X1O2NoCyA - X1O2PlusCyA
MicroRNAs in cancer,141,0.250833316,1,0.425253543,1.00E+00,0.78268721,1,0.396680888,1,X1O2NoCyA - X1O2PlusCyA
Caffeine metabolism,1,NA,NA,0.220229008,1.00E+00,1,1,0.995077322,1,X1O2NoCyA - X1O2PlusCyA
Lipoic acid metabolism,3,NA,NA,0.220229008,1.00E+00,1,1,0.995077322,1,X1O2NoCyA - X1O2PlusCyA
Spinocerebellar ataxia,121,0.100957355,0.95594,0.870852911,1.00E+00,0.971432843,1,0.7357578,1,X1O2NoCyA - X1O2PlusCyA
"Valine, leucine and isoleucine biosynthesis",3,NA,NA,0.39202277,1.00E+00,0.564766174,1,0.439378376,1,X1O2NoCyA - X1O2PlusCyA
NOD-like receptor signaling pathway,135,0.519909919,1,0.177290979,1.00E+00,0.933340736,1,0.503849496,1,X1O2NoCyA - X1O2PlusCyA
Proteoglycans in cancer,149,0.776656955,1,0.162940948,1.00E+00,0.687029008,1,0.519345683,1,X1O2NoCyA - X1O2PlusCyA
Biotin metabolism,3,NA,NA,NA,NA,0.564766174,1,0.564766174,1,X1O2NoCyA - X1O2PlusCyA
Circadian rhythm,23,0.289021513,1,0.863722893,1.00E+00,0.357609031,1,0.58216796,1,X1O2NoCyA - X1O2PlusCyA
Melanogenesis,69,0.250870063,1,0.635696584,1.00E+00,0.572841168,1,0.442630529,1,X1O2NoCyA - X1O2PlusCyA
Ribosome biogenesis in eukaryotes,80,0.092180776,0.9009927,0.998252036,1.00E+00,0.995713077,1,0.979275595,1,X1O2NoCyA - X1O2PlusCyA
Relaxin signaling pathway,88,0.668283531,1,0.395062388,1.00E+00,0.351907054,1,0.486437855,1,X1O2NoCyA - X1O2PlusCyA
Pyrimidine metabolism,45,1,1,0.877142098,1.00E+00,0.106317356,0.763224992,0.999995591,1,X1O2NoCyA - X1O2PlusCyA
Notch signaling pathway,52,0.681173738,1,0.150909749,1.00E+00,0.912692776,1,0.56395374,1,X1O2NoCyA - X1O2PlusCyA
cGMP-PKG signaling pathway,110,0.337280811,1,0.451432372,1.00E+00,0.619207183,1,0.406062889,1,X1O2NoCyA - X1O2PlusCyA
Cocaine addiction,32,1,1,0.734440567,1.00E+00,0.128765783,0.788690419,0.999982715,1,X1O2NoCyA - X1O2PlusCyA
p53 signaling pathway,67,0.775925061,1,0.709321529,1.00E+00,0.172568567,0.896833611,0.688562185,1,X1O2NoCyA - X1O2PlusCyA
Alzheimer disease,300,0.186510259,1,0.51188996,1.00E+00,0.99998361,1,0.849674621,1,X1O2NoCyA - X1O2PlusCyA
Antifolate resistance,25,0.742058018,1,0.362011517,1.00E+00,0.362388942,1,0.524316943,1,X1O2NoCyA - X1O2PlusCyA
Fructose and mannose metabolism,29,0.435137004,1,0.893304937,1.00E+00,0.253389822,1,0.671991408,1,X1O2NoCyA - X1O2PlusCyA
RNA polymerase,31,0.742058018,1,0.137548136,1.00E+00,0.974447474,1,0.680238875,1,X1O2NoCyA - X1O2PlusCyA
Retrograde endocannabinoid signaling,94,0.141640534,1,0.806992749,1.00E+00,0.892022899,1,0.631640357,1,X1O2NoCyA - X1O2PlusCyA
Human cytomegalovirus infection,169,0.855991899,1,0.902241792,1.00E+00,0.133454555,0.789222628,0.866429552,1,X1O2NoCyA - X1O2PlusCyA
DNA replication,36,0.173366498,1,0.966793786,1.00E+00,0.62716318,1,0.758134899,1,X1O2NoCyA - X1O2PlusCyA
Citrate cycle (TCA cycle),29,0.556137169,1,0.264547505,1.00E+00,0.738410013,1,0.471967697,1,X1O2NoCyA - X1O2PlusCyA
Autophagy - animal,124,0.609047858,1,0.416823779,1.00E+00,0.42940518,1,0.490649713,1,X1O2NoCyA - X1O2PlusCyA
RIG-I-like receptor signaling pathway,47,0.90354488,1,0.227971399,1.00E+00,0.537204308,1,0.657377169,1,X1O2NoCyA - X1O2PlusCyA
GABAergic synapse,46,0.556137169,1,0.718844384,1.00E+00,0.280786899,1,0.596886773,1,X1O2NoCyA - X1O2PlusCyA
Herpes simplex virus 1 infection,433,0.966405445,1,0.402004857,1.00E+00,0.290754161,1,0.795740251,1,X1O2NoCyA - X1O2PlusCyA
Phagosome,119,0.803875714,1,0.493470708,1.00E+00,0.294014779,1,0.633676924,1,X1O2NoCyA - X1O2PlusCyA
Dilated cardiomyopathy,51,1,1,0.313283544,1.00E+00,0.373360662,1,0.999904244,1,X1O2NoCyA - X1O2PlusCyA
Arginine biosynthesis,17,NA,NA,0.554756722,1.00E+00,0.510176006,1,0.552287325,1,X1O2NoCyA - X1O2PlusCyA
Diabetic cardiomyopathy,159,0.580385197,1,0.206512318,1.00E+00,0.999616762,1,0.815213173,1,X1O2NoCyA - X1O2PlusCyA
Regulation of actin cytoskeleton,159,0.902459608,1,0.332985422,1.00E+00,0.400597643,1,0.68156041,1,X1O2NoCyA - X1O2PlusCyA
Osteoclast differentiation,98,0.564165208,1,0.303064021,1.00E+00,0.716166481,1,0.496461414,1,X1O2NoCyA - X1O2PlusCyA
Basal transcription factors,42,0.977860637,1,0.137548136,1.00E+00,0.912664567,1,0.871308543,1,X1O2NoCyA - X1O2PlusCyA
beta-Alanine metabolism,23,1,1,0.316289724,1.00E+00,0.40237783,1,0.999916605,1,X1O2NoCyA - X1O2PlusCyA
Kaposi sarcoma-associated herpesvirus infection,150,0.528961033,1,0.318761228,1.00E+00,0.762731953,1,0.506800971,1,X1O2NoCyA - X1O2PlusCyA
African trypanosomiasis,20,1,1,0.208240155,1.00E+00,0.618864381,1,0.999914751,1,X1O2NoCyA - X1O2PlusCyA
Glycosaminoglycan degradation,17,NA,NA,0.775560602,1.00E+00,0.395931358,1,0.697338729,1,X1O2NoCyA - X1O2PlusCyA
VEGF signaling pathway,48,0.851779794,1,0.834378721,1.00E+00,0.186777272,0.903720431,0.834680054,1,X1O2NoCyA - X1O2PlusCyA
Apoptosis,118,0.49981754,1,0.342437705,1.00E+00,0.804814224,1,0.526691147,1,X1O2NoCyA - X1O2PlusCyA
Axon guidance,121,0.338985142,1,0.527790674,1.00E+00,0.784919207,1,0.530658733,1,X1O2NoCyA - X1O2PlusCyA
cAMP signaling pathway,124,0.857457065,1,0.539960744,1.00E+00,0.313344172,1,0.718576817,1,X1O2NoCyA - X1O2PlusCyA
Gap junction,63,0.250870063,1,0.709321529,1.00E+00,0.819549003,1,0.606288088,1,X1O2NoCyA - X1O2PlusCyA
One carbon pool by folate,18,1,1,0.949822997,1.00E+00,0.153683126,0.83671924,0.999999365,1,X1O2NoCyA - X1O2PlusCyA
Drug metabolism - other enzymes,39,0.522552184,1,0.635696584,1.00E+00,0.442074576,1,0.581730243,1,X1O2NoCyA - X1O2PlusCyA
Phosphatidylinositol signaling system,84,0.77560316,1,0.247535041,1.00E+00,0.781648957,1,0.637952776,1,X1O2NoCyA - X1O2PlusCyA
Inositol phosphate metabolism,67,0.600728786,1,0.258828947,1.00E+00,0.965504358,1,0.672757209,1,X1O2NoCyA - X1O2PlusCyA
Pathways in cancer,364,0.874343243,1,0.455769423,1.00E+00,0.377923234,1,0.712307344,1,X1O2NoCyA - X1O2PlusCyA
Apelin signaling pathway,99,0.804852106,1,0.566291496,1.00E+00,0.330804725,1,0.692532692,1,X1O2NoCyA - X1O2PlusCyA
Prion disease,222,0.206177924,1,0.736418024,1.00E+00,0.995232054,1,0.808322407,1,X1O2NoCyA - X1O2PlusCyA
Pantothenate and CoA biosynthesis,16,0.417971624,1,0.383809925,1.00E+00,0.942533996,1,0.610068021,1,X1O2NoCyA - X1O2PlusCyA
PD-L1 expression and PD-1 checkpoint pathway in cancer,78,0.735101165,1,0.280366502,1.00E+00,0.7527908,1,0.616859664,1,X1O2NoCyA - X1O2PlusCyA
"Growth hormone synthesis, secretion and action",88,0.210309331,1,0.944179871,1.00E+00,0.781648957,1,0.789554843,1,X1O2NoCyA - X1O2PlusCyA
Adipocytokine signaling pathway,54,0.770261184,1,0.635696584,1.00E+00,0.317032212,1,0.700889008,1,X1O2NoCyA - X1O2PlusCyA
Pentose and glucuronate interconversions,13,NA,NA,0.893826986,1.00E+00,0.38929831,1,0.823633146,1,X1O2NoCyA - X1O2PlusCyA
Glyoxylate and dicarboxylate metabolism,23,0.417971624,1,0.758316129,1.00E+00,0.496306214,1,0.623964232,1,X1O2NoCyA - X1O2PlusCyA
Olfactory transduction,30,0.417971624,1,0.383809925,1.00E+00,0.983541602,1,0.689316833,1,X1O2NoCyA - X1O2PlusCyA
Fanconi anemia pathway,53,0.937100286,1,0.308500741,1.00E+00,0.55626988,1,0.768313281,1,X1O2NoCyA - X1O2PlusCyA
Non-small cell lung cancer,62,0.600728786,1,0.771839166,1.00E+00,0.349291001,1,0.692168044,1,X1O2NoCyA - X1O2PlusCyA
Ras signaling pathway,150,0.92226733,1,0.507950906,1.00E+00,0.349358642,1,0.78672596,1,X1O2NoCyA - X1O2PlusCyA
Chemical carcinogenesis - DNA adducts,20,1,1,0.18427114,1.00E+00,0.895762494,1,0.999976573,1,X1O2NoCyA - X1O2PlusCyA
HIF-1 signaling pathway,88,0.719444614,1,0.239511049,1.00E+00,0.960553396,1,0.725094425,1,X1O2NoCyA - X1O2PlusCyA
Aldosterone-regulated sodium reabsorption,27,0.742058018,1,0.625292682,1.00E+00,0.362388942,1,0.690681688,1,X1O2NoCyA - X1O2PlusCyA
Glucagon signaling pathway,85,0.45960944,1,0.566291496,1.00E+00,0.653077892,1,0.576739697,1,X1O2NoCyA - X1O2PlusCyA
Histidine metabolism,11,NA,NA,0.712017161,1.00E+00,0.520272762,1,0.693919805,1,X1O2NoCyA - X1O2PlusCyA
Lysine degradation,51,0.887766217,1,0.19763981,1.00E+00,0.978466656,1,0.846950324,1,X1O2NoCyA - X1O2PlusCyA
Breast cancer,107,0.668212421,1,0.291697779,1.00E+00,0.887501284,1,0.654057313,1,X1O2NoCyA - X1O2PlusCyA
Amino sugar and nucleotide sugar metabolism,44,1,1,0.979568293,1.00E+00,0.179848554,0.900072234,0.999999867,1,X1O2NoCyA - X1O2PlusCyA
Base excision repair,33,0.250870063,1,0.712048511,1.00E+00,0.995638562,1,0.824620786,1,X1O2NoCyA - X1O2PlusCyA
Longevity regulating pathway - multiple species,48,0.770261184,1,0.709321529,1.00E+00,0.341869209,1,0.753698498,1,X1O2NoCyA - X1O2PlusCyA
Epithelial cell signaling in Helicobacter pylori infection,60,0.435222827,1,0.61335338,1.00E+00,0.700729769,1,0.611401432,1,X1O2NoCyA - X1O2PlusCyA
Hepatitis C,116,0.857457065,1,0.366982478,1.00E+00,0.605378696,1,0.720055938,1,X1O2NoCyA - X1O2PlusCyA
Other glycan degradation,15,NA,NA,0.712017161,1.00E+00,0.566409552,1,0.714427326,1,X1O2NoCyA - X1O2PlusCyA
Phototransduction,14,NA,NA,0.630523244,1.00E+00,0.643374851,1,0.682277966,1,X1O2NoCyA - X1O2PlusCyA
Mitophagy - animal,65,0.806589556,1,0.255262787,1.00E+00,0.941402418,1,0.771372633,1,X1O2NoCyA - X1O2PlusCyA
Chagas disease,69,0.742058018,1,0.360112488,1.00E+00,0.728690828,1,0.665608831,1,X1O2NoCyA - X1O2PlusCyA
Amoebiasis,59,1,1,0.227971399,1.00E+00,0.859862675,1,0.999979521,1,X1O2NoCyA - X1O2PlusCyA
Ascorbate and aldarate metabolism,7,NA,NA,0.775560602,1.00E+00,0.535325556,1,0.756970499,1,X1O2NoCyA - X1O2PlusCyA
Neurotrophin signaling pathway,100,0.453764887,1,0.539960744,1.00E+00,0.822441529,1,0.635023034,1,X1O2NoCyA - X1O2PlusCyA
Hepatitis B,134,0.760129423,1,0.730021934,1.00E+00,0.369439429,1,0.768217817,1,X1O2NoCyA - X1O2PlusCyA
Chemokine signaling pathway,121,0.719444614,1,0.534956377,1.00E+00,0.540559229,1,0.683400884,1,X1O2NoCyA - X1O2PlusCyA
Tyrosine metabolism,20,NA,NA,0.478311484,1.00E+00,0.895762494,1,0.724000731,1,X1O2NoCyA - X1O2PlusCyA
Human immunodeficiency virus 1 infection,175,0.339909891,1,0.731659373,1.00E+00,0.844553361,1,0.698828791,1,X1O2NoCyA - X1O2PlusCyA
Mineral absorption,35,0.742058018,1,0.478311484,1.00E+00,0.603043426,1,0.688365973,1,X1O2NoCyA - X1O2PlusCyA
Sulfur metabolism,8,NA,NA,0.712017161,1.00E+00,0.613145461,1,0.73490633,1,X1O2NoCyA - X1O2PlusCyA
Glioma,59,0.27049006,1,0.894692586,1.00E+00,0.89181494,1,0.812859329,1,X1O2NoCyA - X1O2PlusCyA
Oxidative phosphorylation,108,1,1,0.219762926,1.00E+00,0.999183418,1,0.999999474,1,X1O2NoCyA - X1O2PlusCyA
Vitamin B6 metabolism,6,NA,NA,1,1.00E+00,0.447319713,1,0.999999967,1,X1O2NoCyA - X1O2PlusCyA
Riboflavin metabolism,7,NA,NA,0.526019279,1.00E+00,0.856563742,1,0.725536224,1,X1O2NoCyA - X1O2PlusCyA
Leukocyte transendothelial migration,81,0.950561878,1,0.896229102,1.00E+00,0.263120294,1,0.951182636,1,X1O2NoCyA - X1O2PlusCyA
"Parathyroid hormone synthesis, secretion and action",78,0.429350557,1,0.857116392,1.00E+00,0.612352126,1,0.753818029,1,X1O2NoCyA - X1O2PlusCyA
Wnt signaling pathway,122,0.337280811,1,0.713164622,1.00E+00,0.942855,1,0.75754502,1,X1O2NoCyA - X1O2PlusCyA
Apoptosis - multiple species,28,0.742058018,1,0.313283544,1.00E+00,0.979593971,1,0.81533815,1,X1O2NoCyA - X1O2PlusCyA
IL-17 signaling pathway,60,0.681173738,1,0.463059687,1.00E+00,0.724960822,1,0.683935662,1,X1O2NoCyA - X1O2PlusCyA
Steroid biosynthesis,19,0.417971624,1,0.848493503,1.00E+00,0.645678116,1,0.750846117,1,X1O2NoCyA - X1O2PlusCyA
Morphine addiction,46,1,1,0.571155812,1.00E+00,0.405424553,1,0.999986336,1,X1O2NoCyA - X1O2PlusCyA
Taste transduction,34,0.23699422,1,1,1.00E+00,0.978996753,1,0.999995617,1,X1O2NoCyA - X1O2PlusCyA
Spliceosome,133,0.236925299,1,0.988991948,1.00E+00,0.999981731,1,0.995446184,1,X1O2NoCyA - X1O2PlusCyA
EGFR tyrosine kinase inhibitor resistance,58,0.580385197,1,0.463059687,1.00E+00,0.878566185,1,0.699371306,1,X1O2NoCyA - X1O2PlusCyA
Glycosphingolipid biosynthesis - ganglio series,14,NA,NA,0.630523244,1.00E+00,0.742317405,1,0.731855549,1,X1O2NoCyA - X1O2PlusCyA
Phosphonate and phosphinate metabolism,5,0.23699422,1,1,1.00E+00,1,1,1,1,X1O2NoCyA - X1O2PlusCyA
Endocrine resistance,83,0.429350557,1,0.798997735,1.00E+00,0.704056733,1,0.736990462,1,X1O2NoCyA - X1O2PlusCyA
Fc gamma R-mediated phagocytosis,77,0.923448476,1,0.806992749,1.00E+00,0.327189541,1,0.907779241,1,X1O2NoCyA - X1O2PlusCyA
Mismatch repair,23,0.362788475,1,0.944224567,1.00E+00,0.725231286,1,0.849413155,1,X1O2NoCyA - X1O2PlusCyA
"Glycine, serine and threonine metabolism",29,1,1,0.875255465,1.00E+00,0.289807031,1,0.999998731,1,X1O2NoCyA - X1O2PlusCyA
Melanoma,46,0.668283531,1,0.758316129,1.00E+00,0.504875197,1,0.771936302,1,X1O2NoCyA - X1O2PlusCyA
Non-alcoholic fatty liver disease,130,0.376112314,1,0.688654002,1.00E+00,0.988458052,1,0.838356721,1,X1O2NoCyA - X1O2PlusCyA
Platinum drug resistance,59,0.547877851,1,0.482599472,1.00E+00,0.97557187,1,0.790813822,1,X1O2NoCyA - X1O2PlusCyA
Tuberculosis,127,0.77560316,1,0.351126517,1.00E+00,0.948162216,1,0.809224036,1,X1O2NoCyA - X1O2PlusCyA
Nicotinate and nicotinamide metabolism,27,0.339724601,1,0.848493503,1.00E+00,0.906293782,1,0.817491479,1,X1O2NoCyA - X1O2PlusCyA
Glycosphingolipid biosynthesis - lacto and neolacto series,18,NA,NA,NA,NA,0.848250135,1,0.848250135,1,X1O2NoCyA - X1O2PlusCyA
Purine metabolism,99,0.568852976,1,0.999957593,1.00E+00,0.465217853,1,0.995766942,1,X1O2NoCyA - X1O2PlusCyA
Chronic myeloid leukemia,69,0.857457065,1,0.95222205,1.00E+00,0.324754151,1,0.946120498,1,X1O2NoCyA - X1O2PlusCyA
Maturity onset diabetes of the young,9,1,1,0.39202277,1.00E+00,0.680550025,1,0.999984977,1,X1O2NoCyA - X1O2PlusCyA
Measles,110,0.998139849,1,0.369998679,1.00E+00,0.733478684,1,0.972970879,1,X1O2NoCyA - X1O2PlusCyA
Nicotine addiction,12,NA,NA,NA,NA,0.860076775,1,0.860076775,1,X1O2NoCyA - X1O2PlusCyA
Glycosaminoglycan biosynthesis - keratan sulfate,11,NA,NA,1,1.00E+00,0.520272762,1,0.999999981,1,X1O2NoCyA - X1O2PlusCyA
Selenocompound metabolism,15,0.556137169,1,0.893826986,1.00E+00,0.566409552,1,0.833227507,1,X1O2NoCyA - X1O2PlusCyA
Propanoate metabolism,32,0.803442221,1,0.630119987,1.00E+00,0.565561047,1,0.79931771,1,X1O2NoCyA - X1O2PlusCyA
Toll-like receptor signaling pathway,68,0.96172388,1,0.370952679,1.00E+00,0.833363179,1,0.906554281,1,X1O2NoCyA - X1O2PlusCyA
Thyroid hormone signaling pathway,100,0.699206,1,0.466639708,1.00E+00,0.916502085,1,0.793944823,1,X1O2NoCyA - X1O2PlusCyA
Amyotrophic lateral sclerosis,302,0.308565973,1,0.992400821,1.00E+00,0.999999785,1,0.999303467,1,X1O2NoCyA - X1O2PlusCyA
"Neomycin, kanamycin and gentamicin biosynthesis",3,NA,NA,1,1.00E+00,0.564766174,1,0.999999986,1,X1O2NoCyA - X1O2PlusCyA
Autophagy - other,30,0.949691846,1,0.428300399,1.00E+00,0.769310056,1,0.893014406,1,X1O2NoCyA - X1O2PlusCyA
Thermogenesis,190,0.453764887,1,0.705226269,1.00E+00,0.999304126,1,0.933887564,1,X1O2NoCyA - X1O2PlusCyA
Ribosome,133,0.378284221,1,0.857508164,1.00E+00,0.999998849,1,0.989586437,1,X1O2NoCyA - X1O2PlusCyA
Hepatocellular carcinoma,131,0.375832741,1,0.90514056,1.00E+00,0.955476152,1,0.903074305,1,X1O2NoCyA - X1O2PlusCyA
Hedgehog signaling pathway,40,0.885951726,1,0.383809925,1.00E+00,0.979458127,1,0.916975233,1,X1O2NoCyA - X1O2PlusCyA
Huntington disease,255,0.477757822,1,0.719472261,1.00E+00,0.999999838,1,0.989516581,1,X1O2NoCyA - X1O2PlusCyA
Pyruvate metabolism,38,0.850257227,1,0.798997735,1.00E+00,0.520224217,1,0.893257874,1,X1O2NoCyA - X1O2PlusCyA
Nitrogen metabolism,8,NA,NA,1,1.00E+00,0.613145461,1,0.99999999,1,X1O2NoCyA - X1O2PlusCyA
Prolactin signaling pathway,52,0.668283531,1,0.672853534,1.00E+00,0.824428439,1,0.825174935,1,X1O2NoCyA - X1O2PlusCyA
Pertussis,51,0.742058018,1,0.506274882,1.00E+00,0.997604719,1,0.936073764,1,X1O2NoCyA - X1O2PlusCyA
Ferroptosis,34,0.600395741,1,0.712048511,1.00E+00,0.88396944,1,0.839006285,1,X1O2NoCyA - X1O2PlusCyA
Cardiac muscle contraction,49,0.556137169,1,0.709321529,1.00E+00,0.95888949,1,0.868663402,1,X1O2NoCyA - X1O2PlusCyA
Lysosome,115,0.775925061,1,0.885645807,1.00E+00,0.56476596,1,0.910181569,1,X1O2NoCyA - X1O2PlusCyA
Cell cycle,118,0.536333884,1,0.985723282,1.00E+00,0.73863351,1,0.958016931,1,X1O2NoCyA - X1O2PlusCyA
Fatty acid biosynthesis,16,1,1,1,1.00E+00,0.395931358,1,1,1,X1O2NoCyA - X1O2PlusCyA
D-Glutamine and D-glutamate metabolism,4,NA,NA,1,1.00E+00,0.67020401,1,0.999999994,1,X1O2NoCyA - X1O2PlusCyA
Rap1 signaling pathway,145,0.999189182,1,0.69427928,1.00E+00,0.618380093,1,0.994003824,1,X1O2NoCyA - X1O2PlusCyA
ErbB signaling pathway,67,0.831009891,1,0.61335338,1.00E+00,0.858334826,1,0.890368735,1,X1O2NoCyA - X1O2PlusCyA
AGE-RAGE signaling pathway in diabetic complications,74,0.91316025,1,0.816015102,1.00E+00,0.587562727,1,0.940840963,1,X1O2NoCyA - X1O2PlusCyA
Metabolism of xenobiotics by cytochrome P450,28,1,1,0.554756722,1.00E+00,0.79105553,1,0.999997583,1,X1O2NoCyA - X1O2PlusCyA
Endocrine and other factor-regulated calcium reabsorption,36,0.742058018,1,0.988826018,1.00E+00,0.603043426,1,0.9777995,1,X1O2NoCyA - X1O2PlusCyA
Carbohydrate digestion and absorption,30,0.556137169,1,0.960924274,1.00E+00,0.843864425,1,0.948011407,1,X1O2NoCyA - X1O2PlusCyA
Regulation of lipolysis in adipocytes,33,1,1,0.935574901,1.00E+00,0.48642999,1,0.999999865,1,X1O2NoCyA - X1O2PlusCyA
Thiamine metabolism,10,NA,NA,0.863722893,1.00E+00,0.826738018,1,0.92276137,1,X1O2NoCyA - X1O2PlusCyA
RNA transport,162,0.468697663,1,0.999955362,1.00E+00,0.999978126,1,0.999976227,1,X1O2NoCyA - X1O2PlusCyA
Thyroid cancer,30,0.91316025,1,0.916171075,1.00E+00,0.565561047,1,0.967962439,1,X1O2NoCyA - X1O2PlusCyA
Primary immunodeficiency,28,0.933894866,1,0.949822997,1.00E+00,0.533917013,1,0.981553966,1,X1O2NoCyA - X1O2PlusCyA
RNA degradation,73,0.519553771,1,0.948604642,1.00E+00,0.989094014,1,0.975878794,1,X1O2NoCyA - X1O2PlusCyA
Collecting duct acid secretion,18,1,1,0.734440567,1.00E+00,0.66713623,1,0.99999895,1,X1O2NoCyA - X1O2PlusCyA
Porphyrin and chlorophyll metabolism,19,1,1,0.625292682,1.00E+00,0.785746867,1,0.999998585,1,X1O2NoCyA - X1O2PlusCyA
Central carbon metabolism in cancer,55,0.770261184,1,0.856578132,1.00E+00,0.758575827,1,0.92605044,1,X1O2NoCyA - X1O2PlusCyA
Carbon metabolism,99,0.728564309,1,0.971976217,1.00E+00,0.716166481,1,0.968558332,1,X1O2NoCyA - X1O2PlusCyA
Starch and sucrose metabolism,27,1,1,1,1.00E+00,0.533917013,1,1,1,X1O2NoCyA - X1O2PlusCyA
mRNA surveillance pathway,83,0.665245148,1,0.963713448,1.00E+00,0.837739977,1,0.966035702,1,X1O2NoCyA - X1O2PlusCyA
Ubiquinone and other terpenoid-quinone biosynthesis,10,NA,NA,1,1.00E+00,0.786405315,1,0.999999998,1,X1O2NoCyA - X1O2PlusCyA
Vasopressin-regulated water reabsorption,35,1,1,0.910320847,1.00E+00,0.603043426,1,0.999999865,1,X1O2NoCyA - X1O2PlusCyA
Yersinia infection,114,0.991426237,1,0.580204534,1.00E+00,0.955446944,1,0.990585629,1,X1O2NoCyA - X1O2PlusCyA
Glycolysis / Gluconeogenesis,51,0.922585407,1,0.960561266,1.00E+00,0.629158933,1,0.986131304,1,X1O2NoCyA - X1O2PlusCyA
Pathogenic Escherichia coli infection,162,0.940300175,1,0.720970116,1.00E+00,0.832292421,1,0.96183482,1,X1O2NoCyA - X1O2PlusCyA
Homologous recombination,41,0.694513782,1,0.97018726,1.00E+00,0.851904753,1,0.974956788,1,X1O2NoCyA - X1O2PlusCyA
Glutathione metabolism,37,0.661591335,1,0.937173593,1.00E+00,0.926265063,1,0.966065742,1,X1O2NoCyA - X1O2PlusCyA
Salmonella infection,227,0.993943452,1,0.666304188,1.00E+00,0.871755235,1,0.990885107,1,X1O2NoCyA - X1O2PlusCyA
Pentose phosphate pathway,26,0.885951726,1,1,1.00E+00,0.668071756,1,0.99999982,1,X1O2NoCyA - X1O2PlusCyA
Galactose metabolism,24,0.742058018,1,0.916171075,1.00E+00,0.88856482,1,0.963401035,1,X1O2NoCyA - X1O2PlusCyA
Tight junction,133,0.973912545,1,0.87598224,1.00E+00,0.743666452,1,0.988558057,1,X1O2NoCyA - X1O2PlusCyA
Fatty acid degradation,35,1,1,0.673882473,1.00E+00,0.949720953,1,0.999999826,1,X1O2NoCyA - X1O2PlusCyA
Drug metabolism - cytochrome P450,25,1,1,0.775560602,1.00E+00,0.844179139,1,0.999999781,1,X1O2NoCyA - X1O2PlusCyA
Shigellosis,215,0.904120129,1,0.877786356,1.00E+00,0.844854116,1,0.97739017,1,X1O2NoCyA - X1O2PlusCyA
"Alanine, aspartate and glutamate metabolism",24,1,1,0.969572795,1.00E+00,0.725231286,1,0.99999999,1,X1O2NoCyA - X1O2PlusCyA
Synaptic vesicle cycle,52,1,1,0.798997735,1.00E+00,0.923498933,1,0.99999993,1,X1O2NoCyA - X1O2PlusCyA
Coronavirus disease - COVID-19,174,0.793360666,1,0.963454318,1.00E+00,0.999973091,1,0.99943483,1,X1O2NoCyA - X1O2PlusCyA
Renin-angiotensin system,10,1,1,0.825102122,1.00E+00,0.937649437,1,0.99999996,1,X1O2NoCyA - X1O2PlusCyA
Primary bile acid biosynthesis,9,NA,NA,1,1.00E+00,0.937649437,1,1,1,X1O2NoCyA - X1O2PlusCyA
Phenylalanine metabolism,11,NA,NA,1,1.00E+00,0.952773849,1,1,1,X1O2NoCyA - X1O2PlusCyA
Tryptophan metabolism,26,1,1,0.848493503,1.00E+00,0.968832904,1,0.999999986,1,X1O2NoCyA - X1O2PlusCyA
Non-homologous end-joining,13,1,1,1,1.00E+00,0.860076775,1,1,1,X1O2NoCyA - X1O2PlusCyA
Proteasome,45,0.885951726,1,0.98482995,1.00E+00,0.994638905,1,0.999262467,1,X1O2NoCyA - X1O2PlusCyA
Bacterial invasion of epithelial cells,64,0.99574278,1,0.882347892,1.00E+00,0.994829618,1,0.999752364,1,X1O2NoCyA - X1O2PlusCyA
Endocytosis,217,0.994164463,1,0.930839963,1.00E+00,0.989453317,1,0.999771068,1,X1O2NoCyA - X1O2PlusCyA
"Phenylalanine, tyrosine and tryptophan biosynthesis",3,NA,NA,1,1.00E+00,1,1,1,1,X1O2NoCyA - X1O2PlusCyA
Taurine and hypotaurine metabolism,5,NA,NA,1,1.00E+00,1,1,1,1,X1O2NoCyA - X1O2PlusCyA
Glycosphingolipid biosynthesis - globo and isoglobo series,11,NA,NA,1,1.00E+00,1,1,1,1,X1O2NoCyA - X1O2PlusCyA
Ribosome,133,0.669017421,1,2.87E-11,9.74E-09,1,1,0.064559221,1,X1O2NoCyA - X19O2NoCyA
Coronavirus disease - COVID-19,174,0.914509186,1,1.25E-08,2.11E-06,0.99922766,1,0.066391619,1,X1O2NoCyA - X19O2NoCyA
Autoimmune thyroid disease,28,0.709779881,1,3.67E-06,4.14E-04,0.621185676,1,0.007527361,0.64908281,X1O2NoCyA - X19O2NoCyA
Allograft rejection,28,0.709779881,1,1.74E-05,1.18E-03,0.621185676,1,0.013650324,0.64908281,X1O2NoCyA - X19O2NoCyA
Graft-versus-host disease,29,0.709779881,1,1.74E-05,1.18E-03,0.660713491,1,0.015138958,0.64908281,X1O2NoCyA - X19O2NoCyA
Staphylococcus aureus infection,38,0.52363579,1,5.99E-05,2.90E-03,0.547716412,1,0.007902881,0.64908281,X1O2NoCyA - X19O2NoCyA
Systemic lupus erythematosus,96,0.390922785,1,0.044313668,6.82E-01,0.001421356,0.320248552,0.007407288,0.64908281,X1O2NoCyA - X19O2NoCyA
Type I diabetes mellitus,31,0.7735513,1,5.99E-05,2.90E-03,0.731616473,1,0.038495688,0.91080694,X1O2NoCyA - X19O2NoCyA
Cell adhesion molecules,81,0.507926523,1,0.000258751,9.75E-03,0.362222893,0.991424631,0.008714395,0.64908281,X1O2NoCyA - X19O2NoCyA
Asthma,19,0.628136217,1,0.000222996,9.45E-03,0.813914937,1,0.042486621,0.91080694,X1O2NoCyA - X19O2NoCyA
Cushing syndrome,110,0.015947539,0.5514195,0.404484985,1.00E+00,0.052270027,0.755748916,0.014300828,0.64908281,X1O2NoCyA - X19O2NoCyA
Tuberculosis,127,0.189466483,1,0.003678969,1.05E-01,0.603831591,1,0.013338185,0.64908281,X1O2NoCyA - X19O2NoCyA
HIF-1 signaling pathway,88,0.289988131,1,0.07333961,8.53E-01,0.020711637,0.527115666,0.018266745,0.69616595,X1O2NoCyA - X19O2NoCyA
Rheumatoid arthritis,63,0.628136217,1,0.011745863,2.84E-01,0.059846676,0.760274436,0.0317001,0.91080694,X1O2NoCyA - X19O2NoCyA
Intestinal immune network for IgA production,35,0.823351222,1,0.001166785,3.96E-02,0.594226412,1,0.100831948,1,X1O2NoCyA - X19O2NoCyA
Viral myocarditis,51,0.367537376,1,0.003717136,1.05E-01,0.712519877,1,0.040543841,0.91080694,X1O2NoCyA - X19O2NoCyA
Alcoholism,140,0.848168271,1,0.722235721,1.00E+00,0.001867338,0.320248552,0.476210431,1,X1O2NoCyA - X19O2NoCyA
Linoleic acid metabolism,9,NA,NA,NA,NA,0.041731617,0.7533655,0.041731617,0.91080694,X1O2NoCyA - X19O2NoCyA
Terpenoid backbone biosynthesis,21,1,1,0.081602726,8.92E-01,0.022499656,0.527115666,0.993659364,1,X1O2NoCyA - X19O2NoCyA
Hematopoietic cell lineage,53,0.619447607,1,0.017019838,3.39E-01,0.179285078,0.991424631,0.062885017,1,X1O2NoCyA - X19O2NoCyA
Hippo signaling pathway,118,0.044879595,0.9713227,0.11864744,1.00E+00,0.375119009,0.991424631,0.022616301,0.77573913,X1O2NoCyA - X19O2NoCyA
Antigen processing and presentation,55,0.367537376,1,0.014211695,3.21E-01,0.393676195,0.991424631,0.040140292,0.91080694,X1O2NoCyA - X19O2NoCyA
Glycerophospholipid metabolism,66,0.679436653,1,0.016694865,3.39E-01,0.241955041,0.991424631,0.089186279,1,X1O2NoCyA - X19O2NoCyA
Herpes simplex virus 1 infection,433,0.874628519,1,0.511799931,1.00E+00,0.006811978,0.470352547,0.429346622,1,X1O2NoCyA - X19O2NoCyA
Leishmaniasis,59,0.445174681,1,0.01148106,2.84E-01,0.637601201,1,0.076100557,1,X1O2NoCyA - X19O2NoCyA
Transcriptional misregulation in cancer,126,0.684308361,1,0.688470271,1.00E+00,0.008602772,0.470352547,0.388282704,1,X1O2NoCyA - X19O2NoCyA
Lysine degradation,51,0.668412648,1,0.142199303,1.00E+00,0.046420322,0.755748916,0.145238908,1,X1O2NoCyA - X19O2NoCyA
PPAR signaling pathway,49,1,1,0.048002602,6.82E-01,0.092637022,0.860669327,0.995046023,1,X1O2NoCyA - X19O2NoCyA
Fructose and mannose metabolism,29,1,1,0.402329017,1.00E+00,0.011155445,0.470352547,0.999124843,1,X1O2NoCyA - X19O2NoCyA
Necroptosis,125,0.01796087,0.5514195,0.646473915,1.00E+00,0.393618249,0.991424631,0.10838766,1,X1O2NoCyA - X19O2NoCyA
Starch and sucrose metabolism,27,0.390922785,1,0.609942032,1.00E+00,0.02165361,0.527115666,0.218125531,1,X1O2NoCyA - X19O2NoCyA
Other glycan degradation,15,NA,NA,0.328560228,1.00E+00,0.066047769,0.809085171,0.125089034,1,X1O2NoCyA - X19O2NoCyA
Oxytocin signaling pathway,110,0.335568993,1,0.039674221,6.40E-01,0.422847657,1,0.067737466,1,X1O2NoCyA - X19O2NoCyA
Melanogenesis,69,0.069938361,1,0.494173868,1.00E+00,0.164272638,0.991424631,0.087929553,1,X1O2NoCyA - X19O2NoCyA
Amyotrophic lateral sclerosis,302,0.005981416,0.5514195,0.999984425,1.00E+00,0.999999997,1,0.999499898,1,X1O2NoCyA - X19O2NoCyA
Alzheimer disease,300,0.006838766,0.5514195,0.875936394,1.00E+00,1,1,0.935122358,1,X1O2NoCyA - X19O2NoCyA
Lysosome,115,0.731494869,1,0.646906693,1.00E+00,0.013712902,0.470352547,0.420787582,1,X1O2NoCyA - X19O2NoCyA
Viral carcinogenesis,179,0.945991772,1,0.999049892,1.00E+00,0.006998331,0.470352547,0.983169993,1,X1O2NoCyA - X19O2NoCyA
Pathways of neurodegeneration - multiple diseases,380,0.007268335,0.5514195,0.973211974,1.00E+00,0.999999744,1,0.943609832,1,X1O2NoCyA - X19O2NoCyA
Basal cell carcinoma,43,0.55118886,1,0.132844142,1.00E+00,0.101384317,0.860669327,0.129413282,1,X1O2NoCyA - X19O2NoCyA
Biosynthesis of amino acids,66,0.776208538,1,0.754822223,1.00E+00,0.013340752,0.470352547,0.536765596,1,X1O2NoCyA - X19O2NoCyA
Tyrosine metabolism,20,NA,NA,1,1.00E+00,0.032110729,0.683558826,0.999997018,1,X1O2NoCyA - X19O2NoCyA
Neutrophil extracellular trap formation,138,0.936236144,1,0.896645788,1.00E+00,0.009855218,0.470352547,0.821482578,1,X1O2NoCyA - X19O2NoCyA
Ubiquitin mediated proteolysis,131,0.03421617,0.7975,0.494593465,1.00E+00,0.490117892,1,0.112581662,1,X1O2NoCyA - X19O2NoCyA
ABC transporters,29,0.218827415,1,0.141310322,1.00E+00,0.28230866,0.991424631,0.076566236,1,X1O2NoCyA - X19O2NoCyA
Estrogen signaling pathway,84,0.076440187,1,0.583560811,1.00E+00,0.196041795,0.991424631,0.129301521,1,X1O2NoCyA - X19O2NoCyA
Toxoplasmosis,94,0.47727759,1,0.048260035,6.82E-01,0.383160293,0.991424631,0.109108254,1,X1O2NoCyA - X19O2NoCyA
RNA polymerase,31,0.072993932,1,0.171207755,1.00E+00,0.712736748,1,0.087943258,1,X1O2NoCyA - X19O2NoCyA
Pentose phosphate pathway,26,0.245440504,1,0.988847007,1.00E+00,0.040427156,0.7533655,0.640635064,1,X1O2NoCyA - X19O2NoCyA
Axon guidance,121,0.012034033,0.5514195,0.957942081,1.00E+00,0.881913779,1,0.539485557,1,X1O2NoCyA - X19O2NoCyA
Spinocerebellar ataxia,121,0.010815593,0.5514195,0.951751669,1.00E+00,0.9994892,1,0.799233986,1,X1O2NoCyA - X19O2NoCyA
Prion disease,222,0.012034033,0.5514195,0.96450583,1.00E+00,0.99995803,1,0.886574144,1,X1O2NoCyA - X19O2NoCyA
Folate biosynthesis,15,1,1,0.035760461,6.06E-01,0.335544191,0.991424631,0.997718057,1,X1O2NoCyA - X19O2NoCyA
Inflammatory mediator regulation of TRP channels,64,0.892579553,1,0.180153735,1.00E+00,0.075941872,0.846209902,0.369603095,1,X1O2NoCyA - X19O2NoCyA
Progesterone-mediated oocyte maturation,81,0.020018528,0.5514195,0.665230587,1.00E+00,0.994466512,1,0.463982261,1,X1O2NoCyA - X19O2NoCyA
Sphingolipid metabolism,38,0.52363579,1,0.486997516,1.00E+00,0.052816179,0.755748916,0.272402261,1,X1O2NoCyA - X19O2NoCyA
Galactose metabolism,24,0.709779881,1,0.356104733,1.00E+00,0.056186388,0.755748916,0.312517368,1,X1O2NoCyA - X19O2NoCyA
Choline metabolism in cancer,72,0.404919862,1,0.142199303,1.00E+00,0.247185459,0.991424631,0.13215586,1,X1O2NoCyA - X19O2NoCyA
Fat digestion and absorption,21,NA,NA,0.058181549,7.59E-01,0.892728284,1,0.236528082,1,X1O2NoCyA - X19O2NoCyA
Biosynthesis of cofactors,111,1,1,0.646789636,1.00E+00,0.02273947,0.527115666,0.999866105,1,X1O2NoCyA - X19O2NoCyA
Circadian rhythm,23,0.074533347,1,0.276290818,1.00E+00,0.718896414,1,0.133843128,1,X1O2NoCyA - X19O2NoCyA
Proteasome,45,0.015114988,0.5514195,0.997323435,1.00E+00,1,1,0.99773265,1,X1O2NoCyA - X19O2NoCyA
alpha-Linolenic acid metabolism,11,NA,NA,0.546604307,1.00E+00,0.099661212,0.860669327,0.289803629,1,X1O2NoCyA - X19O2NoCyA
Glycolysis / Gluconeogenesis,51,0.715248792,1,0.386695999,1.00E+00,0.055599736,0.755748916,0.334457187,1,X1O2NoCyA - X19O2NoCyA
Caffeine metabolism,1,NA,NA,0.231679389,1.00E+00,0.240452354,0.991424631,0.161018332,1,X1O2NoCyA - X19O2NoCyA
Insulin signaling pathway,114,0.907342701,1,0.031211749,5.88E-01,0.588769646,1,0.399198237,1,X1O2NoCyA - X19O2NoCyA
Chemical carcinogenesis - DNA adducts,20,1,1,0.206317701,1.00E+00,0.083880865,0.846209902,0.999054859,1,X1O2NoCyA - X19O2NoCyA
Insulin secretion,49,0.55118886,1,0.931216696,1.00E+00,0.033879009,0.683558826,0.635050929,1,X1O2NoCyA - X19O2NoCyA
Huntington disease,255,0.018302273,0.5514195,0.983906377,1.00E+00,0.999999913,1,0.97902133,1,X1O2NoCyA - X19O2NoCyA
Apoptosis,118,0.06967397,1,0.546172224,1.00E+00,0.478845397,1,0.180308503,1,X1O2NoCyA - X19O2NoCyA
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,15,NA,NA,0.231679389,1.00E+00,0.282227085,0.991424631,0.17756593,1,X1O2NoCyA - X19O2NoCyA
Sulfur relay system,8,1,1,0.842331213,1.00E+00,0.023051705,0.527115666,0.999974863,1,X1O2NoCyA - X19O2NoCyA
GnRH signaling pathway,74,0.069938361,1,0.522786648,1.00E+00,0.580363777,1,0.196950788,1,X1O2NoCyA - X19O2NoCyA
Glycerolipid metabolism,44,0.7735513,1,0.035406485,6.06E-01,0.788763986,1,0.354792358,1,X1O2NoCyA - X19O2NoCyA
Phosphatidylinositol signaling system,84,0.518592002,1,0.200175954,1.00E+00,0.214321069,0.991424631,0.205956012,1,X1O2NoCyA - X19O2NoCyA
AMPK signaling pathway,97,0.99491172,1,0.229382944,1.00E+00,0.100717616,0.860669327,0.761596742,1,X1O2NoCyA - X19O2NoCyA
"Neomycin, kanamycin and gentamicin biosynthesis",3,NA,NA,0.546604307,1.00E+00,0.145594625,0.991424631,0.330809669,1,X1O2NoCyA - X19O2NoCyA
Small cell lung cancer,75,0.566774037,1,0.758234677,1.00E+00,0.05728709,0.755748916,0.483064049,1,X1O2NoCyA - X19O2NoCyA
Chemical carcinogenesis - receptor activation,123,0.080411674,1,0.968990989,1.00E+00,0.316482839,0.991424631,0.5433277,1,X1O2NoCyA - X19O2NoCyA
Protein processing in endoplasmic reticulum,157,0.027019863,0.6822516,0.945306633,1.00E+00,0.974992585,1,0.702535072,1,X1O2NoCyA - X19O2NoCyA
Gastric cancer,105,0.453189114,1,0.220303446,1.00E+00,0.259639558,0.991424631,0.204344047,1,X1O2NoCyA - X19O2NoCyA
Hippo signaling pathway - multiple species,21,0.709779881,1,0.141310322,1.00E+00,0.263883247,0.991424631,0.281396732,1,X1O2NoCyA - X19O2NoCyA
Pathways in cancer,364,0.344824443,1,0.225431357,1.00E+00,0.348711281,0.991424631,0.18372461,1,X1O2NoCyA - X19O2NoCyA
Fanconi anemia pathway,53,0.589368761,1,0.355746557,1.00E+00,0.136940021,0.991424631,0.303783473,1,X1O2NoCyA - X19O2NoCyA
Signaling pathways regulating pluripotency of stem cells,99,0.404919862,1,0.431313329,1.00E+00,0.173199418,0.991424631,0.26342824,1,X1O2NoCyA - X19O2NoCyA
Retinol metabolism,19,NA,NA,0.328560228,1.00E+00,0.296466942,0.991424631,0.256399801,1,X1O2NoCyA - X19O2NoCyA
"Glycine, serine and threonine metabolism",29,1,1,0.110414199,1.00E+00,0.28230866,0.991424631,0.999192864,1,X1O2NoCyA - X19O2NoCyA
Phenylalanine metabolism,11,NA,NA,1,1.00E+00,0.099661212,0.860669327,0.999999271,1,X1O2NoCyA - X19O2NoCyA
Various types of N-glycan biosynthesis,34,0.389910667,1,0.110414199,1.00E+00,0.771791287,1,0.244587461,1,X1O2NoCyA - X19O2NoCyA
Antifolate resistance,25,0.709779881,1,0.221387809,1.00E+00,0.212327414,0.991424631,0.328649721,1,X1O2NoCyA - X19O2NoCyA
Glycosphingolipid biosynthesis - globo and isoglobo series,11,NA,NA,0.136045602,1.00E+00,0.782716203,1,0.292505853,1,X1O2NoCyA - X19O2NoCyA
Biosynthesis of unsaturated fatty acids,22,1,1,0.206324818,1.00E+00,0.166487816,0.991424631,0.99945342,1,X1O2NoCyA - X19O2NoCyA
Steroid biosynthesis,19,0.389910667,1,0.663496823,1.00E+00,0.135708761,0.991424631,0.369654295,1,X1O2NoCyA - X19O2NoCyA
Breast cancer,107,0.389351843,1,0.216256687,1.00E+00,0.420877659,1,0.22037755,1,X1O2NoCyA - X19O2NoCyA
Cortisol synthesis and secretion,39,0.390922785,1,0.914765435,1.00E+00,0.102878841,0.860669327,0.587601128,1,X1O2NoCyA - X19O2NoCyA
Adherens junction,63,0.057004457,1,0.704401145,1.00E+00,0.945201708,1,0.471707516,1,X1O2NoCyA - X19O2NoCyA
Inflammatory bowel disease,41,0.7735513,1,0.075465307,8.53E-01,0.65078715,1,0.385316089,1,X1O2NoCyA - X19O2NoCyA
Primary immunodeficiency,28,0.916262098,1,0.805211041,1.00E+00,0.052574744,0.755748916,0.799446065,1,X1O2NoCyA - X19O2NoCyA
Apoptosis - multiple species,28,0.072993932,1,0.791380984,1.00E+00,0.697555769,1,0.410233451,1,X1O2NoCyA - X19O2NoCyA
Nicotine addiction,12,NA,NA,NA,NA,0.383707498,0.991424631,0.383707498,1,X1O2NoCyA - X19O2NoCyA
Fluid shear stress and atherosclerosis,96,0.821204927,1,0.064571148,8.11E-01,0.819580369,1,0.487812209,1,X1O2NoCyA - X19O2NoCyA
Type II diabetes mellitus,29,1,1,0.527145683,1.00E+00,0.083615362,0.846209902,0.999884581,1,X1O2NoCyA - X19O2NoCyA
Phagosome,119,0.345542269,1,0.252399055,1.00E+00,0.527091583,1,0.252215002,1,X1O2NoCyA - X19O2NoCyA
Thyroid hormone synthesis,50,0.312283245,1,0.752746683,1.00E+00,0.196580449,0.991424631,0.418390666,1,X1O2NoCyA - X19O2NoCyA
Malaria,24,NA,NA,0.182619205,1.00E+00,0.745054796,1,0.329010549,1,X1O2NoCyA - X19O2NoCyA
Cocaine addiction,32,0.210134509,1,1,1.00E+00,0.222258896,0.991424631,0.999531633,1,X1O2NoCyA - X19O2NoCyA
Lipid and atherosclerosis,159,0.456699118,1,0.209285884,1.00E+00,0.489095228,1,0.271854773,1,X1O2NoCyA - X19O2NoCyA
Long-term potentiation,52,0.172345049,1,0.352202698,1.00E+00,0.796732149,1,0.292462847,1,X1O2NoCyA - X19O2NoCyA
African trypanosomiasis,20,1,1,0.237298215,1.00E+00,0.205917598,0.991424631,0.999650377,1,X1O2NoCyA - X19O2NoCyA
Oocyte meiosis,108,0.098252511,1,0.501165633,1.00E+00,0.998722479,1,0.624422565,1,X1O2NoCyA - X19O2NoCyA
Relaxin signaling pathway,88,0.312283245,1,0.873518817,1.00E+00,0.181477496,0.991424631,0.528406778,1,X1O2NoCyA - X19O2NoCyA
Endometrial cancer,52,0.260326327,1,0.354286912,1.00E+00,0.544435565,1,0.267338179,1,X1O2NoCyA - X19O2NoCyA
"Valine, leucine and isoleucine biosynthesis",3,NA,NA,1,1.00E+00,0.145594625,0.991424631,0.999999596,1,X1O2NoCyA - X19O2NoCyA
Lipoic acid metabolism,3,NA,NA,1,1.00E+00,0.145594625,0.991424631,0.999999596,1,X1O2NoCyA - X19O2NoCyA
MicroRNAs in cancer,141,0.680626798,1,0.745927751,1.00E+00,0.102776275,0.860669327,0.598699764,1,X1O2NoCyA - X19O2NoCyA
Circadian entrainment,60,0.18135032,1,0.402329017,1.00E+00,0.725851935,1,0.299392897,1,X1O2NoCyA - X19O2NoCyA
Neurotrophin signaling pathway,100,0.351725544,1,0.164357235,1.00E+00,0.916156874,1,0.362220793,1,X1O2NoCyA - X19O2NoCyA
Complement and coagulation cascades,36,1,1,0.058181549,7.59E-01,0.910337158,1,0.999877641,1,X1O2NoCyA - X19O2NoCyA
Aldosterone synthesis and secretion,62,0.814287539,1,0.210905751,1.00E+00,0.308644999,0.991424631,0.448979827,1,X1O2NoCyA - X19O2NoCyA
Amphetamine addiction,48,0.379491421,1,0.355746557,1.00E+00,0.395133324,0.991424631,0.293287757,1,X1O2NoCyA - X19O2NoCyA
Central carbon metabolism in cancer,55,0.896150856,1,0.497423513,1.00E+00,0.120155595,0.958450445,0.644129563,1,X1O2NoCyA - X19O2NoCyA
IL-17 signaling pathway,60,0.172345049,1,0.522786648,1.00E+00,0.60147855,1,0.314437627,1,X1O2NoCyA - X19O2NoCyA
Autophagy - other,30,0.069938361,1,0.894674571,1.00E+00,0.881098686,1,0.617882245,1,X1O2NoCyA - X19O2NoCyA
Th1 and Th2 cell differentiation,75,0.896150856,1,0.07352791,8.53E-01,0.85597721,1,0.615391257,1,X1O2NoCyA - X19O2NoCyA
Human T-cell leukemia virus 1 infection,192,0.470079392,1,0.43214475,1.00E+00,0.279936,0.991424631,0.350196266,1,X1O2NoCyA - X19O2NoCyA
mTOR signaling pathway,131,0.440265477,1,0.186774685,1.00E+00,0.707100091,1,0.320392636,1,X1O2NoCyA - X19O2NoCyA
Peroxisome,70,1,1,0.813618759,1.00E+00,0.071551006,0.846209902,0.999985759,1,X1O2NoCyA - X19O2NoCyA
Mannose type O-glycan biosynthesis,19,NA,NA,0.231679389,1.00E+00,0.70525424,1,0.361093375,1,X1O2NoCyA - X19O2NoCyA
Glycosaminoglycan degradation,17,NA,NA,0.42218518,1.00E+00,0.389555272,0.991424631,0.37755318,1,X1O2NoCyA - X19O2NoCyA
Prostate cancer,73,0.296233701,1,0.652054623,1.00E+00,0.314593825,0.991424631,0.388580655,1,X1O2NoCyA - X19O2NoCyA
Drug metabolism - cytochrome P450,25,1,1,0.794645636,1.00E+00,0.077998031,0.846209902,0.999983967,1,X1O2NoCyA - X19O2NoCyA
Amino sugar and nucleotide sugar metabolism,44,0.122839112,1,0.951182856,1.00E+00,0.53270028,1,0.635478281,1,X1O2NoCyA - X19O2NoCyA
Butanoate metabolism,17,1,1,0.161781214,1.00E+00,0.389555272,0.991424631,0.999688249,1,X1O2NoCyA - X19O2NoCyA
"Growth hormone synthesis, secretion and action",88,0.302261579,1,0.98673499,1.00E+00,0.214321069,0.991424631,0.787113297,1,X1O2NoCyA - X19O2NoCyA
Carbohydrate digestion and absorption,30,1,1,0.609942032,1.00E+00,0.112478935,0.918577973,0.999948692,1,X1O2NoCyA - X19O2NoCyA
Platinum drug resistance,59,0.715248792,1,0.24711393,1.00E+00,0.391859451,0.991424631,0.429818253,1,X1O2NoCyA - X19O2NoCyA
Cholinergic synapse,73,0.379491421,1,0.522786648,1.00E+00,0.363086698,0.991424631,0.382501174,1,X1O2NoCyA - X19O2NoCyA
Glucagon signaling pathway,85,0.843059811,1,0.486737256,1.00E+00,0.178581753,0.991424631,0.611792126,1,X1O2NoCyA - X19O2NoCyA
Primary bile acid biosynthesis,9,NA,NA,1,1.00E+00,0.202088017,0.991424631,0.999999775,1,X1O2NoCyA - X19O2NoCyA
AGE-RAGE signaling pathway in diabetic complications,74,1,1,0.976510164,1.00E+00,0.081676999,0.846209902,0.999999575,1,X1O2NoCyA - X19O2NoCyA
TNF signaling pathway,84,0.529452029,1,0.311819062,1.00E+00,0.485118579,1,0.38795934,1,X1O2NoCyA - X19O2NoCyA
Salmonella infection,227,0.199218663,1,0.469014063,1.00E+00,0.858854956,1,0.424672545,1,X1O2NoCyA - X19O2NoCyA
Vitamin digestion and absorption,12,1,1,0.585945956,1.00E+00,0.138323043,0.991424631,0.999950369,1,X1O2NoCyA - X19O2NoCyA
Fc epsilon RI signaling pathway,53,0.133508948,1,0.811450754,1.00E+00,0.749385464,1,0.541835755,1,X1O2NoCyA - X19O2NoCyA
Drug metabolism - other enzymes,39,0.474751771,1,0.941129391,1.00E+00,0.182199915,0.991424631,0.73407014,1,X1O2NoCyA - X19O2NoCyA
Spliceosome,133,0.084358734,1,0.967330511,1.00E+00,0.999997748,1,0.980363793,1,X1O2NoCyA - X19O2NoCyA
Th17 cell differentiation,89,0.707955866,1,0.176087984,1.00E+00,0.676687942,1,0.472565324,1,X1O2NoCyA - X19O2NoCyA
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,25,1,1,0.136045602,1.00E+00,0.621185676,1,0.999825497,1,X1O2NoCyA - X19O2NoCyA
Renal cell carcinoma,56,0.500353969,1,0.279391609,1.00E+00,0.609621386,1,0.392831113,1,X1O2NoCyA - X19O2NoCyA
Pantothenate and CoA biosynthesis,16,1,1,0.418897707,1.00E+00,0.205917598,0.991424631,0.999900909,1,X1O2NoCyA - X19O2NoCyA
Phototransduction,14,NA,NA,0.231115749,1.00E+00,0.97212444,1,0.634352874,1,X1O2NoCyA - X19O2NoCyA
Epstein-Barr virus infection,176,0.864714121,1,0.259329654,1.00E+00,0.40914691,1,0.584959123,1,X1O2NoCyA - X19O2NoCyA
Viral protein interaction with cytokine and cytokine receptor,30,0.389910667,1,0.842331213,1.00E+00,0.28230866,0.991424631,0.597559699,1,X1O2NoCyA - X19O2NoCyA
Mismatch repair,23,0.111755022,1,0.851958486,1.00E+00,0.988443982,1,0.775049909,1,X1O2NoCyA - X19O2NoCyA
Arginine and proline metabolism,35,0.218827415,1,0.459124361,1.00E+00,0.947416095,1,0.519374952,1,X1O2NoCyA - X19O2NoCyA
T cell receptor signaling pathway,79,0.189466483,1,0.586942419,1.00E+00,0.865176816,1,0.496426422,1,X1O2NoCyA - X19O2NoCyA
Colorectal cancer,77,0.404919862,1,0.520956454,1.00E+00,0.463500324,1,0.436870337,1,X1O2NoCyA - X19O2NoCyA
Nucleotide excision repair,46,0.155464169,1,0.637497263,1.00E+00,0.993008515,1,0.69526197,1,X1O2NoCyA - X19O2NoCyA
Mucin type O-glycan biosynthesis,20,NA,NA,1,1.00E+00,0.250042551,0.991424631,0.999999853,1,X1O2NoCyA - X19O2NoCyA
Autophagy - animal,124,0.143411807,1,0.726482821,1.00E+00,0.98373069,1,0.697160898,1,X1O2NoCyA - X19O2NoCyA
Ovarian steroidogenesis,24,0.218827415,1,0.653926471,1.00E+00,0.718896414,1,0.488656148,1,X1O2NoCyA - X19O2NoCyA
Hypertrophic cardiomyopathy,48,1,1,0.527145683,1.00E+00,0.196580449,0.991424631,0.999948985,1,X1O2NoCyA - X19O2NoCyA
N-Glycan biosynthesis,47,0.389910667,1,0.508972709,1.00E+00,0.52626122,1,0.443031794,1,X1O2NoCyA - X19O2NoCyA
Glycosaminoglycan biosynthesis - keratan sulfate,11,NA,NA,1,1.00E+00,0.26061762,0.991424631,0.999999866,1,X1O2NoCyA - X19O2NoCyA
B cell receptor signaling pathway,74,0.559455005,1,0.852459917,1.00E+00,0.226142543,0.991424631,0.687448804,1,X1O2NoCyA - X19O2NoCyA
Parkinson disease,211,0.113918539,1,0.957232027,1.00E+00,0.999999965,1,0.991867462,1,X1O2NoCyA - X19O2NoCyA
Synthesis and degradation of ketone bodies,7,1,1,0.206317701,1.00E+00,0.531072516,1,0.999877912,1,X1O2NoCyA - X19O2NoCyA
Ribosome biogenesis in eukaryotes,80,0.118236321,1,0.979676823,1.00E+00,0.957255411,1,0.887983618,1,X1O2NoCyA - X19O2NoCyA
ErbB signaling pathway,67,0.415796009,1,0.349747805,1.00E+00,0.770291898,1,0.458117788,1,X1O2NoCyA - X19O2NoCyA
Cholesterol metabolism,33,0.709779881,1,0.19416122,1.00E+00,0.821404262,1,0.56225805,1,X1O2NoCyA - X19O2NoCyA
Aminoacyl-tRNA biosynthesis,44,0.379491421,1,0.999590567,1.00E+00,0.301424569,0.991424631,0.961796034,1,X1O2NoCyA - X19O2NoCyA
Insulin resistance,88,0.908600852,1,0.249602161,1.00E+00,0.50559722,1,0.669982078,1,X1O2NoCyA - X19O2NoCyA
Neuroactive ligand-receptor interaction,108,0.7735513,1,0.354360279,1.00E+00,0.420877659,1,0.568492671,1,X1O2NoCyA - X19O2NoCyA
ECM-receptor interaction,43,1,1,0.486997516,1.00E+00,0.237362361,0.991424631,0.999946443,1,X1O2NoCyA - X19O2NoCyA
Arrhythmogenic right ventricular cardiomyopathy,40,1,1,0.180858279,1.00E+00,0.65078715,1,0.999903189,1,X1O2NoCyA - X19O2NoCyA
Hepatitis B,134,0.673845949,1,0.802675435,1.00E+00,0.218084997,0.991424631,0.708266498,1,X1O2NoCyA - X19O2NoCyA
Thiamine metabolism,10,NA,NA,0.878957678,1.00E+00,0.321764908,0.991424631,0.779388771,1,X1O2NoCyA - X19O2NoCyA
Glycosaminoglycan biosynthesis - heparan sulfate / heparin,14,NA,NA,0.409751406,1.00E+00,0.690799165,1,0.523048527,1,X1O2NoCyA - X19O2NoCyA
Vascular smooth muscle contraction,81,0.755062385,1,0.547053158,1.00E+00,0.291495002,0.991424631,0.624758681,1,X1O2NoCyA - X19O2NoCyA
Riboflavin metabolism,7,NA,NA,0.546604307,1.00E+00,0.531072516,1,0.55585895,1,X1O2NoCyA - X19O2NoCyA
Sphingolipid signaling pathway,99,0.404919862,1,0.954872796,1.00E+00,0.316763465,0.991424631,0.776047152,1,X1O2NoCyA - X19O2NoCyA
2-Oxocarboxylic acid metabolism,17,NA,NA,0.870250776,1.00E+00,0.335544191,0.991424631,0.77435357,1,X1O2NoCyA - X19O2NoCyA
Homologous recombination,41,0.625367941,1,0.602304959,1.00E+00,0.329777512,0.991424631,0.582495705,1,X1O2NoCyA - X19O2NoCyA
Phospholipase D signaling pathway,102,0.186846404,1,0.813618759,1.00E+00,0.826345971,1,0.639719982,1,X1O2NoCyA - X19O2NoCyA
Sulfur metabolism,8,NA,NA,1,1.00E+00,0.297760445,0.991424631,0.999999901,1,X1O2NoCyA - X19O2NoCyA
Vasopressin-regulated water reabsorption,35,0.474751771,1,0.928757047,1.00E+00,0.288674188,0.991424631,0.756912918,1,X1O2NoCyA - X19O2NoCyA
"Parathyroid hormone synthesis, secretion and action",78,0.930547571,1,0.960123348,1.00E+00,0.142711613,0.991424631,0.955128493,1,X1O2NoCyA - X19O2NoCyA
Glycosphingolipid biosynthesis - lacto and neolacto series,18,NA,NA,NA,NA,0.66112149,1,0.66112149,1,X1O2NoCyA - X19O2NoCyA
Fatty acid metabolism,50,1,1,0.788404899,1.00E+00,0.163711969,0.991424631,0.999991961,1,X1O2NoCyA - X19O2NoCyA
MAPK signaling pathway,205,0.2789503,1,0.827131959,1.00E+00,0.578642634,1,0.619700315,1,X1O2NoCyA - X19O2NoCyA
mRNA surveillance pathway,83,0.140310117,1,0.996376491,1.00E+00,0.962161953,1,0.957371695,1,X1O2NoCyA - X19O2NoCyA
Osteoclast differentiation,98,0.831765595,1,0.64850697,1.00E+00,0.257449679,0.991424631,0.734651832,1,X1O2NoCyA - X19O2NoCyA
Olfactory transduction,30,0.389910667,1,0.418897707,1.00E+00,0.861393816,1,0.54073727,1,X1O2NoCyA - X19O2NoCyA
Wnt signaling pathway,122,0.598634731,1,0.252393706,1.00E+00,0.937818724,1,0.626448526,1,X1O2NoCyA - X19O2NoCyA
Influenza A,128,0.495281316,1,0.773034871,1.00E+00,0.372840177,0.991424631,0.638226396,1,X1O2NoCyA - X19O2NoCyA
Focal adhesion,139,0.247059774,1,0.838746254,1.00E+00,0.696395722,1,0.652581838,1,X1O2NoCyA - X19O2NoCyA
Glycosphingolipid biosynthesis - ganglio series,14,NA,NA,0.65176716,1.00E+00,0.504031193,1,0.633330831,1,X1O2NoCyA - X19O2NoCyA
Cellular senescence,136,0.95933011,1,0.158718541,1.00E+00,0.95664577,1,0.875569258,1,X1O2NoCyA - X19O2NoCyA
Human papillomavirus infection,248,0.932509557,1,0.758355791,1.00E+00,0.206011297,0.991424631,0.868489541,1,X1O2NoCyA - X19O2NoCyA
One carbon pool by folate,18,1,1,0.295105182,1.00E+00,0.495623678,1,0.999932287,1,X1O2NoCyA - X19O2NoCyA
PI3K-Akt signaling pathway,223,0.411395323,1,0.479908371,1.00E+00,0.751036104,1,0.532478545,1,X1O2NoCyA - X19O2NoCyA
Pyrimidine metabolism,45,0.55118886,1,0.992788617,1.00E+00,0.271794709,0.991424631,0.924989582,1,X1O2NoCyA - X19O2NoCyA
Chagas disease,69,0.709779881,1,0.423839827,1.00E+00,0.500682875,1,0.594164026,1,X1O2NoCyA - X19O2NoCyA
Inositol phosphate metabolism,67,0.529452029,1,0.470637393,1.00E+00,0.612960339,1,0.544253068,1,X1O2NoCyA - X19O2NoCyA
Dopaminergic synapse,93,0.31176814,1,0.694562091,1.00E+00,0.717358102,1,0.591020459,1,X1O2NoCyA - X19O2NoCyA
Long-term depression,43,0.312283245,1,0.997046648,1.00E+00,0.499072802,1,0.928717716,1,X1O2NoCyA - X19O2NoCyA
Taurine and hypotaurine metabolism,5,NA,NA,1,1.00E+00,0.347047068,0.991424631,0.999999932,1,X1O2NoCyA - X19O2NoCyA
Measles,110,0.908952954,1,0.578250384,1.00E+00,0.297587339,0.991424631,0.787660986,1,X1O2NoCyA - X19O2NoCyA
Purine metabolism,99,0.776208538,1,0.996233848,1.00E+00,0.205357605,0.991424631,0.972364251,1,X1O2NoCyA - X19O2NoCyA
Metabolism of xenobiotics by cytochrome P450,28,1,1,0.585945956,1.00E+00,0.274269324,0.991424631,0.999977514,1,X1O2NoCyA - X19O2NoCyA
Base excision repair,33,0.204336059,1,0.896601739,1.00E+00,0.87955499,1,0.76730476,1,X1O2NoCyA - X19O2NoCyA
Kaposi sarcoma-associated herpesvirus infection,150,0.854153749,1,0.315193135,1.00E+00,0.609532008,1,0.686459382,1,X1O2NoCyA - X19O2NoCyA
Natural killer cell mediated cytotoxicity,81,0.545886822,1,0.748207203,1.00E+00,0.411116648,1,0.664021673,1,X1O2NoCyA - X19O2NoCyA
Pathogenic Escherichia coli infection,162,0.242751025,1,0.801266562,1.00E+00,0.865419693,1,0.697748388,1,X1O2NoCyA - X19O2NoCyA
Glyoxylate and dicarboxylate metabolism,23,1,1,0.180858279,1.00E+00,0.94018553,1,0.999985258,1,X1O2NoCyA - X19O2NoCyA
Gap junction,63,0.204336059,1,0.960123348,1.00E+00,0.886240558,1,0.85569133,1,X1O2NoCyA - X19O2NoCyA
Cytokine-cytokine receptor interaction,113,0.93473882,1,0.674141861,1.00E+00,0.279373265,0.991424631,0.855253452,1,X1O2NoCyA - X19O2NoCyA
Hedgehog signaling pathway,40,0.245440504,1,0.928686903,1.00E+00,0.780443639,1,0.787737165,1,X1O2NoCyA - X19O2NoCyA
Toll-like receptor signaling pathway,68,0.776208538,1,0.277830913,1.00E+00,0.825202813,1,0.682751157,1,X1O2NoCyA - X19O2NoCyA
Notch signaling pathway,52,0.846483577,1,0.579773667,1.00E+00,0.363422866,0.991424631,0.747250527,1,X1O2NoCyA - X19O2NoCyA
FoxO signaling pathway,107,0.635889238,1,0.54195864,1.00E+00,0.530950669,1,0.627848246,1,X1O2NoCyA - X19O2NoCyA
Bladder cancer,33,0.862231559,1,0.550961628,1.00E+00,0.395991762,0.991424631,0.756929721,1,X1O2NoCyA - X19O2NoCyA
Serotonergic synapse,65,1,1,0.988533199,1.00E+00,0.19472415,0.991424631,0.999999947,1,X1O2NoCyA - X19O2NoCyA
Synaptic vesicle cycle,52,1,1,0.694777426,1.00E+00,0.279145735,0.991424631,0.999990477,1,X1O2NoCyA - X19O2NoCyA
GnRH secretion,41,0.7735513,1,0.94463351,1.00E+00,0.267098148,0.991424631,0.901223263,1,X1O2NoCyA - X19O2NoCyA
Dilated cardiomyopathy,51,1,1,0.791380984,1.00E+00,0.248199676,0.991424631,0.999995403,1,X1O2NoCyA - X19O2NoCyA
Epithelial cell signaling in Helicobacter pylori infection,60,0.679436653,1,0.509322062,1.00E+00,0.573330415,1,0.652457106,1,X1O2NoCyA - X19O2NoCyA
Legionellosis,41,0.679436653,1,0.580778661,1.00E+00,0.504641037,1,0.670932156,1,X1O2NoCyA - X19O2NoCyA
EGFR tyrosine kinase inhibitor resistance,58,0.302261579,1,0.836912661,1.00E+00,0.792267505,1,0.729675989,1,X1O2NoCyA - X19O2NoCyA
Pertussis,51,0.709779881,1,0.355746557,1.00E+00,0.817271728,1,0.681082917,1,X1O2NoCyA - X19O2NoCyA
Nicotinate and nicotinamide metabolism,27,0.709779881,1,0.663496823,1.00E+00,0.439030024,1,0.718158638,1,X1O2NoCyA - X19O2NoCyA
Morphine addiction,46,0.628136217,1,0.840714497,1.00E+00,0.395133324,0.991424631,0.776282977,1,X1O2NoCyA - X19O2NoCyA
Arginine biosynthesis,17,NA,NA,0.585945956,1.00E+00,0.737491158,1,0.69531602,1,X1O2NoCyA - X19O2NoCyA
Proteoglycans in cancer,149,0.680626798,1,0.425313635,1.00E+00,0.738044149,1,0.666739643,1,X1O2NoCyA - X19O2NoCyA
Mineral absorption,35,0.709779881,1,0.508532172,1.00E+00,0.594226412,1,0.680141721,1,X1O2NoCyA - X19O2NoCyA
Collecting duct acid secretion,18,1,1,0.486997516,1.00E+00,0.44321401,1,0.999978818,1,X1O2NoCyA - X19O2NoCyA
NF-kappa B signaling pathway,79,0.737873451,1,0.601919652,1.00E+00,0.48872642,1,0.717141516,1,X1O2NoCyA - X19O2NoCyA
Cytosolic DNA-sensing pathway,41,0.892579553,1,0.312145529,1.00E+00,0.780443639,1,0.786124737,1,X1O2NoCyA - X19O2NoCyA
Arachidonic acid metabolism,25,1,1,0.794645636,1.00E+00,0.274269324,0.991424631,0.999996155,1,X1O2NoCyA - X19O2NoCyA
Vitamin B6 metabolism,6,NA,NA,1,1.00E+00,0.443315769,1,0.999999966,1,X1O2NoCyA - X19O2NoCyA
Selenocompound metabolism,15,1,1,0.653926471,1.00E+00,0.335544191,0.991424631,0.999989959,1,X1O2NoCyA - X19O2NoCyA
Diabetic cardiomyopathy,159,0.302261579,1,0.744112673,1.00E+00,0.981453997,1,0.813152356,1,X1O2NoCyA - X19O2NoCyA
Other types of O-glycan biosynthesis,35,1,1,0.878957678,1.00E+00,0.254737278,0.991424631,0.999998538,1,X1O2NoCyA - X19O2NoCyA
Cell cycle,118,0.684308361,1,0.527823494,1.00E+00,0.647242444,1,0.693368183,1,X1O2NoCyA - X19O2NoCyA
Aldosterone-regulated sodium reabsorption,27,1,1,0.663496823,1.00E+00,0.354477874,0.991424631,0.999991488,1,X1O2NoCyA - X19O2NoCyA
Salivary secretion,55,1,1,0.71543415,1.00E+00,0.33356084,0.991424631,0.999993915,1,X1O2NoCyA - X19O2NoCyA
Amoebiasis,59,1,1,0.62113986,1.00E+00,0.393676195,0.991424631,0.999990087,1,X1O2NoCyA - X19O2NoCyA
Adipocytokine signaling pathway,54,1,1,0.312145529,1.00E+00,0.78366766,1,0.999983699,1,X1O2NoCyA - X19O2NoCyA
Glioma,59,0.423039774,1,0.812406586,1.00E+00,0.714849097,1,0.747723188,1,X1O2NoCyA - X19O2NoCyA
Apelin signaling pathway,99,0.875186997,1,0.344252796,1.00E+00,0.833661115,1,0.807163723,1,X1O2NoCyA - X19O2NoCyA
Basal transcription factors,42,0.621111308,1,0.494173868,1.00E+00,0.826156258,1,0.71034765,1,X1O2NoCyA - X19O2NoCyA
Carbon metabolism,99,0.670629192,1,0.726482821,1.00E+00,0.520914737,1,0.758310947,1,X1O2NoCyA - X19O2NoCyA
Glutathione metabolism,37,1,1,0.865179594,1.00E+00,0.293800431,0.991424631,0.999998555,1,X1O2NoCyA - X19O2NoCyA
TGF-beta signaling pathway,72,0.679436653,1,0.754693858,1.00E+00,0.496485898,1,0.773347792,1,X1O2NoCyA - X19O2NoCyA
Ras signaling pathway,150,0.437808309,1,0.708623144,1.00E+00,0.822954513,1,0.729442636,1,X1O2NoCyA - X19O2NoCyA
Renin secretion,38,0.709779881,1,0.71149611,1.00E+00,0.510803382,1,0.768851066,1,X1O2NoCyA - X19O2NoCyA
p53 signaling pathway,67,1,1,0.580778661,1.00E+00,0.445878251,1,0.99998933,1,X1O2NoCyA - X19O2NoCyA
Prolactin signaling pathway,52,0.312283245,1,0.876051016,1.00E+00,0.947526184,1,0.854088894,1,X1O2NoCyA - X19O2NoCyA
Bile secretion,34,0.7735513,1,0.413574464,1.00E+00,0.817126988,1,0.757605745,1,X1O2NoCyA - X19O2NoCyA
GABAergic synapse,46,0.52363579,1,0.754038517,1.00E+00,0.669192232,1,0.74338627,1,X1O2NoCyA - X19O2NoCyA
Hepatocellular carcinoma,131,0.581586929,1,0.935873256,1.00E+00,0.490117892,1,0.867230438,1,X1O2NoCyA - X19O2NoCyA
NOD-like receptor signaling pathway,135,0.558723417,1,0.658578682,1.00E+00,0.733595815,1,0.726569215,1,X1O2NoCyA - X19O2NoCyA
Fc gamma R-mediated phagocytosis,77,0.891678972,1,0.967375743,1.00E+00,0.314593825,0.991424631,0.965726098,1,X1O2NoCyA - X19O2NoCyA
Histidine metabolism,11,NA,NA,1,1.00E+00,0.51498845,1,0.99999998,1,X1O2NoCyA - X19O2NoCyA
C-type lectin receptor signaling pathway,82,0.99467506,1,0.533282605,1.00E+00,0.51376183,1,0.959235535,1,X1O2NoCyA - X19O2NoCyA
Maturity onset diabetes of the young,9,1,1,0.409751406,1.00E+00,0.676353661,1,0.999986559,1,X1O2NoCyA - X19O2NoCyA
Adrenergic signaling in cardiomyocytes,93,0.679436653,1,0.741450915,1.00E+00,0.557681107,1,0.78296144,1,X1O2NoCyA - X19O2NoCyA
Non-small cell lung cancer,62,0.914962652,1,0.917746133,1.00E+00,0.3373131,0.991424631,0.949559548,1,X1O2NoCyA - X19O2NoCyA
Thyroid hormone signaling pathway,100,0.762961568,1,0.673479317,1.00E+00,0.560983924,1,0.794004546,1,X1O2NoCyA - X19O2NoCyA
"Alanine, aspartate and glutamate metabolism",24,0.389910667,1,0.870250776,1.00E+00,0.863993002,1,0.83451981,1,X1O2NoCyA - X19O2NoCyA
Calcium signaling pathway,129,0.668412648,1,0.677303816,1.00E+00,0.655160083,1,0.769805552,1,X1O2NoCyA - X19O2NoCyA
Propanoate metabolism,32,0.7735513,1,0.459124361,1.00E+00,0.840324819,1,0.790730081,1,X1O2NoCyA - X19O2NoCyA
"Valine, leucine and isoleucine degradation",42,0.52363579,1,0.694777426,1.00E+00,0.826156258,1,0.767748199,1,X1O2NoCyA - X19O2NoCyA
Regulation of actin cytoskeleton,159,0.456778113,1,0.731186963,1.00E+00,0.94564873,1,0.828186296,1,X1O2NoCyA - X19O2NoCyA
Longevity regulating pathway,73,0.92213538,1,0.952704246,1.00E+00,0.363086698,0.991424631,0.970048913,1,X1O2NoCyA - X19O2NoCyA
Cysteine and methionine metabolism,42,0.823351222,1,0.834389956,1.00E+00,0.464865358,1,0.88602427,1,X1O2NoCyA - X19O2NoCyA
Thyroid cancer,30,0.892579553,1,0.931216696,1.00E+00,0.395991762,0.991424631,0.953134718,1,X1O2NoCyA - X19O2NoCyA
Platelet activation,90,0.453189114,1,0.772458611,1.00E+00,0.940742631,1,0.843589295,1,X1O2NoCyA - X19O2NoCyA
SNARE interactions in vesicular transport,33,0.474751771,1,0.752746683,1.00E+00,0.926450999,1,0.831632281,1,X1O2NoCyA - X19O2NoCyA
Endocrine resistance,83,0.578957819,1,0.836912661,1.00E+00,0.691831663,1,0.831803002,1,X1O2NoCyA - X19O2NoCyA
Ferroptosis,34,0.55118886,1,0.971501478,1.00E+00,0.630143102,1,0.92626742,1,X1O2NoCyA - X19O2NoCyA
RIG-I-like receptor signaling pathway,47,0.975980743,1,0.902697626,1.00E+00,0.394462502,0.991424631,0.979097265,1,X1O2NoCyA - X19O2NoCyA
cAMP signaling pathway,124,0.805725887,1,0.490105238,1.00E+00,0.887460421,1,0.845286531,1,X1O2NoCyA - X19O2NoCyA
Nitrogen metabolism,8,NA,NA,1,1.00E+00,0.608843207,1,0.99999999,1,X1O2NoCyA - X19O2NoCyA
Chronic myeloid leukemia,69,0.923699678,1,0.917520987,1.00E+00,0.416475707,1,0.96066081,1,X1O2NoCyA - X19O2NoCyA
Protein export,23,0.52363579,1,0.993442876,1.00E+00,0.680558608,1,0.966435316,1,X1O2NoCyA - X19O2NoCyA
VEGF signaling pathway,48,0.566774037,1,0.951486182,1.00E+00,0.657660776,1,0.910602464,1,X1O2NoCyA - X19O2NoCyA
beta-Alanine metabolism,23,1,1,0.907086579,1.00E+00,0.394671374,0.991424631,0.999999582,1,X1O2NoCyA - X19O2NoCyA
Melanoma,46,0.619447607,1,0.791380984,1.00E+00,0.750692487,1,0.838139987,1,X1O2NoCyA - X19O2NoCyA
Tryptophan metabolism,26,1,1,0.870250776,1.00E+00,0.439030024,1,0.999999363,1,X1O2NoCyA - X19O2NoCyA
Rap1 signaling pathway,145,0.518592002,1,0.761267063,1.00E+00,0.970676131,1,0.888814186,1,X1O2NoCyA - X19O2NoCyA
Human cytomegalovirus infection,169,0.880430864,1,0.982678165,1.00E+00,0.468818784,1,0.982727863,1,X1O2NoCyA - X19O2NoCyA
Non-alcoholic fatty liver disease,130,0.529452029,1,0.766666836,1.00E+00,0.999859264,1,0.972575469,1,X1O2NoCyA - X19O2NoCyA
Non-homologous end-joining,13,0.474751771,1,1,1.00E+00,0.857066957,1,0.999996623,1,X1O2NoCyA - X19O2NoCyA
Vibrio cholerae infection,44,1,1,0.902697626,1.00E+00,0.499072802,1,0.999999731,1,X1O2NoCyA - X19O2NoCyA
JAK-STAT signaling pathway,86,0.873538098,1,0.88526791,1.00E+00,0.586827666,1,0.946796135,1,X1O2NoCyA - X19O2NoCyA
Gastric acid secretion,46,0.892579553,1,0.71543415,1.00E+00,0.711453678,1,0.918902502,1,X1O2NoCyA - X19O2NoCyA
Shigellosis,215,0.737550702,1,0.841486711,1.00E+00,0.785518576,1,0.914870118,1,X1O2NoCyA - X19O2NoCyA
Regulation of lipolysis in adipocytes,33,1,1,0.762836139,1.00E+00,0.644214122,1,0.999999113,1,X1O2NoCyA - X19O2NoCyA
Fatty acid biosynthesis,16,1,1,0.805211041,1.00E+00,0.612697606,1,0.999999349,1,X1O2NoCyA - X19O2NoCyA
Pyruvate metabolism,38,1,1,0.522786648,1.00E+00,0.955722626,1,0.999999423,1,X1O2NoCyA - X19O2NoCyA
Human immunodeficiency virus 1 infection,175,0.989265893,1,0.5698762,1.00E+00,0.909198972,1,0.983679826,1,X1O2NoCyA - X19O2NoCyA
Hepatitis C,116,0.805725887,1,0.954855799,1.00E+00,0.671445527,1,0.9668538,1,X1O2NoCyA - X19O2NoCyA
Porphyrin and chlorophyll metabolism,19,1,1,0.870250776,1.00E+00,0.593932662,1,0.999999705,1,X1O2NoCyA - X19O2NoCyA
Endocytosis,217,0.797351165,1,0.682496884,1.00E+00,0.958899141,1,0.936161851,1,X1O2NoCyA - X19O2NoCyA
Ether lipid metabolism,27,1,1,0.842331213,1.00E+00,0.621185676,1,0.999999612,1,X1O2NoCyA - X19O2NoCyA
DNA replication,36,0.566774037,1,0.976510164,1.00E+00,0.991879511,1,0.9899964,1,X1O2NoCyA - X19O2NoCyA
Glutamatergic synapse,74,0.823351222,1,0.84215064,1.00E+00,0.815386488,1,0.945867709,1,X1O2NoCyA - X19O2NoCyA
Acute myeloid leukemia,56,0.891678972,1,0.758234677,1.00E+00,0.841267911,1,0.950537496,1,X1O2NoCyA - X19O2NoCyA
Yersinia infection,114,0.646769599,1,0.906239501,1.00E+00,0.971024586,1,0.966615116,1,X1O2NoCyA - X19O2NoCyA
Proximal tubule bicarbonate reclamation,16,1,1,0.585945956,1.00E+00,0.983943775,1,0.99999986,1,X1O2NoCyA - X19O2NoCyA
Leukocyte transendothelial migration,81,1,1,0.924741799,1.00E+00,0.639839019,1,0.999999921,1,X1O2NoCyA - X19O2NoCyA
PD-L1 expression and PD-1 checkpoint pathway in cancer,78,0.953993983,1,0.76742333,1.00E+00,0.822319967,1,0.97350209,1,X1O2NoCyA - X19O2NoCyA
Protein digestion and absorption,42,1,1,0.907086579,1.00E+00,0.682002543,1,0.999999907,1,X1O2NoCyA - X19O2NoCyA
Steroid hormone biosynthesis,19,NA,NA,1,1.00E+00,0.844473626,1,0.999999999,1,X1O2NoCyA - X19O2NoCyA
cGMP-PKG signaling pathway,110,0.963344618,1,0.868737957,1.00E+00,0.766910643,1,0.985463216,1,X1O2NoCyA - X19O2NoCyA
Tight junction,133,0.894605915,1,0.779490049,1.00E+00,0.929283305,1,0.970433337,1,X1O2NoCyA - X19O2NoCyA
Endocrine and other factor-regulated calcium reabsorption,36,0.709779881,1,0.991447801,1.00E+00,0.937721652,1,0.993837067,1,X1O2NoCyA - X19O2NoCyA
Thermogenesis,190,0.910901799,1,0.725320748,1.00E+00,0.999794327,1,0.995758065,1,X1O2NoCyA - X19O2NoCyA
Pancreatic secretion,56,0.916262098,1,0.928757047,1.00E+00,0.78366766,1,0.98460284,1,X1O2NoCyA - X19O2NoCyA
Mitophagy - animal,65,0.914962652,1,0.762608901,1.00E+00,0.96856709,1,0.981242472,1,X1O2NoCyA - X19O2NoCyA
Fatty acid elongation,21,1,1,0.870250776,1.00E+00,0.780612945,1,0.999999901,1,X1O2NoCyA - X19O2NoCyA
Pancreatic cancer,69,1,1,0.959991521,1.00E+00,0.739630296,1,0.999999986,1,X1O2NoCyA - X19O2NoCyA
Longevity regulating pathway - multiple species,48,0.981302736,1,0.88526791,1.00E+00,0.831138192,1,0.994037152,1,X1O2NoCyA - X19O2NoCyA
Pentose and glucuronate interconversions,13,NA,NA,0.907086579,1.00E+00,1,1,0.99999414,1,X1O2NoCyA - X19O2NoCyA
Oxidative phosphorylation,108,1,1,0.726482821,1.00E+00,0.999869202,1,0.999999999,1,X1O2NoCyA - X19O2NoCyA
Chemokine signaling pathway,121,0.79569555,1,0.972795257,1.00E+00,0.947482259,1,0.992141597,1,X1O2NoCyA - X19O2NoCyA
Fatty acid degradation,35,1,1,0.951486182,1.00E+00,0.771791287,1,0.999999984,1,X1O2NoCyA - X19O2NoCyA
Taste transduction,34,1,1,1,1.00E+00,0.74346165,1,1,1,X1O2NoCyA - X19O2NoCyA
Bacterial invasion of epithelial cells,64,0.993151184,1,0.961691217,1.00E+00,0.818568215,1,0.999085248,1,X1O2NoCyA - X19O2NoCyA
RNA degradation,73,0.805725887,1,0.995109539,1.00E+00,0.988124031,1,0.999077693,1,X1O2NoCyA - X19O2NoCyA
Ubiquinone and other terpenoid-quinone biosynthesis,10,NA,NA,1,1.00E+00,0.951616058,1,1,1,X1O2NoCyA - X19O2NoCyA
Citrate cycle (TCA cycle),29,1,1,0.84215064,1.00E+00,0.9827372,1,0.999999991,1,X1O2NoCyA - X19O2NoCyA
RNA transport,162,0.845219284,1,0.998466692,1.00E+00,0.999278481,1,0.999932306,1,X1O2NoCyA - X19O2NoCyA
Retrograde endocannabinoid signaling,94,1,1,0.924741799,1.00E+00,0.927967647,1,0.999999993,1,X1O2NoCyA - X19O2NoCyA
Cardiac muscle contraction,49,1,1,0.960123348,1.00E+00,0.956596198,1,0.999999999,1,X1O2NoCyA - X19O2NoCyA
Renin-angiotensin system,10,1,1,1,1.00E+00,0.936261525,1,1,1,X1O2NoCyA - X19O2NoCyA
Ascorbate and aldarate metabolism,7,NA,NA,1,1.00E+00,1,1,1,1,X1O2NoCyA - X19O2NoCyA
"Phenylalanine, tyrosine and tryptophan biosynthesis",3,NA,NA,1,1.00E+00,1,1,1,1,X1O2NoCyA - X19O2NoCyA
Phosphonate and phosphinate metabolism,5,1,1,1,1.00E+00,1,1,1,1,X1O2NoCyA - X19O2NoCyA
D-Glutamine and D-glutamate metabolism,4,NA,NA,1,1.00E+00,1,1,1,1,X1O2NoCyA - X19O2NoCyA
Biotin metabolism,3,NA,NA,NA,NA,1,1,1,1,X1O2NoCyA - X19O2NoCyA
Ribosome,133,0.540673098,1,1.03E-12,1.74E-10,0.99805081,1,0.000352175,0.06039806,X1O2PlusCyA - X19O2NoCyA
Coronavirus disease - COVID-19,174,0.771439331,1,1.03E-12,1.74E-10,0.753426777,1,0.0000681,0.02334754,X1O2PlusCyA - X19O2NoCyA
Protein processing in endoplasmic reticulum,157,0.16597374,1,0.310444946,1.00E+00,0.000000214,0.0000734,0.001837914,0.2101348,X1O2PlusCyA - X19O2NoCyA
"Valine, leucine and isoleucine degradation",42,0.136303003,1,0.00042801,4.84E-02,0.741893882,1,0.0042113,0.36111898,X1O2PlusCyA - X19O2NoCyA
Aminoacyl-tRNA biosynthesis,44,0.182954934,1,0.244546757,1.00E+00,0.003862567,0.370724195,0.019316381,0.7015833,X1O2PlusCyA - X19O2NoCyA
Fructose and mannose metabolism,29,1,1,0.476689536,1.00E+00,0.000405251,0.069500605,0.99776132,1,X1O2PlusCyA - X19O2NoCyA
Cytokine-cytokine receptor interaction,113,0.237838421,1,0.074363175,8.78E-01,0.017776112,0.531064654,0.013374842,0.7015833,X1O2PlusCyA - X19O2NoCyA
Terpenoid backbone biosynthesis,21,0.041009889,1,0.009735581,4.13E-01,0.983981765,1,0.033488429,0.76576875,X1O2PlusCyA - X19O2NoCyA
Mucin type O-glycan biosynthesis,20,NA,NA,0.154428288,1.00E+00,0.017521483,0.531064654,0.025561202,0.7015833,X1O2PlusCyA - X19O2NoCyA
Vitamin B6 metabolism,6,NA,NA,0.681251222,1.00E+00,0.004323314,0.370724195,0.175149674,1,X1O2PlusCyA - X19O2NoCyA
Allograft rejection,28,0.32928406,1,0.002606939,1.77E-01,0.648491326,1,0.025158683,0.7015833,X1O2PlusCyA - X19O2NoCyA
Glycolysis / Gluconeogenesis,51,0.528941519,1,0.057218588,8.08E-01,0.018579521,0.531064654,0.03750721,0.80406081,X1O2PlusCyA - X19O2NoCyA
Graft-versus-host disease,29,0.32928406,1,0.002606939,1.77E-01,0.687266955,1,0.027676554,0.7015833,X1O2PlusCyA - X19O2NoCyA
Lipoic acid metabolism,3,NA,NA,0.248473282,1.00E+00,0.014965232,0.531064654,0.045355515,0.81881682,X1O2PlusCyA - X19O2NoCyA
Cell adhesion molecules,81,0.295883426,1,0.108444601,9.87E-01,0.023996997,0.587926426,0.02773034,0.7015833,X1O2PlusCyA - X19O2NoCyA
p53 signaling pathway,67,0.945958527,1,0.014299886,4.71E-01,0.080641783,0.785684535,0.181981766,1,X1O2PlusCyA - X19O2NoCyA
Type I diabetes mellitus,31,0.423144676,1,0.005315109,3.00E-01,0.597099891,1,0.0453572,0.81881682,X1O2PlusCyA - X19O2NoCyA
Glycosphingolipid biosynthesis - ganglio series,14,NA,NA,0.049793463,8.02E-01,0.140612285,0.927500267,0.024640321,0.7015833,X1O2PlusCyA - X19O2NoCyA
Malaria,24,NA,NA,0.07596827,8.78E-01,0.094865171,0.831919439,0.028636053,0.7015833,X1O2PlusCyA - X19O2NoCyA
Autoimmune thyroid disease,28,0.32928406,1,0.007176626,3.48E-01,0.648491326,1,0.041544577,0.81881682,X1O2PlusCyA - X19O2NoCyA
Apoptosis - multiple species,28,0.085064204,1,0.03839039,6.85E-01,0.555822125,1,0.02303959,0.7015833,X1O2PlusCyA - X19O2NoCyA
Tuberculosis,127,0.125119267,1,0.03588321,6.85E-01,0.416330803,1,0.022500257,0.7015833,X1O2PlusCyA - X19O2NoCyA
Alzheimer disease,300,0.002488465,0.7540049,0.874068475,1.00E+00,0.994282678,1,0.45111206,1,X1O2PlusCyA - X19O2NoCyA
Tyrosine metabolism,20,NA,NA,0.864961424,1.00E+00,0.01240866,0.531064654,0.422268806,1,X1O2PlusCyA - X19O2NoCyA
Synthesis and degradation of ketone bodies,7,0.232039637,1,0.012421614,4.68E-01,0.862359753,1,0.064613831,1,X1O2PlusCyA - X19O2NoCyA
Histidine metabolism,11,NA,NA,0.363964594,1.00E+00,0.032030164,0.732423086,0.106795157,1,X1O2PlusCyA - X19O2NoCyA
Central carbon metabolism in cancer,55,0.528941519,1,0.105159172,9.87E-01,0.049997438,0.785684535,0.08081921,1,X1O2PlusCyA - X19O2NoCyA
Antigen processing and presentation,55,0.665394145,1,0.203097265,1.00E+00,0.023113515,0.587926426,0.152172384,1,X1O2PlusCyA - X19O2NoCyA
Biosynthesis of amino acids,66,0.806756698,1,0.025862901,6.28E-01,0.157176571,0.929509721,0.139327522,1,X1O2PlusCyA - X19O2NoCyA
Other glycan degradation,15,NA,NA,0.101710895,9.87E-01,0.18038458,0.934467112,0.059365217,1,X1O2PlusCyA - X19O2NoCyA
Toxoplasmosis,94,0.528941519,1,0.145657951,1.00E+00,0.058382237,0.785684535,0.107133405,1,X1O2PlusCyA - X19O2NoCyA
Other types of O-glycan biosynthesis,35,1,1,0.629457867,1.00E+00,0.007213069,0.494816535,0.999712017,1,X1O2PlusCyA - X19O2NoCyA
Platinum drug resistance,59,0.75606361,1,0.113602742,9.87E-01,0.055039631,0.785684535,0.172330358,1,X1O2PlusCyA - X19O2NoCyA
Glycosaminoglycan degradation,17,NA,NA,0.03662384,6.85E-01,0.635067533,1,0.086187673,1,X1O2PlusCyA - X19O2NoCyA
Legionellosis,41,0.714209374,1,0.174470639,1.00E+00,0.048222747,0.785684535,0.190038244,1,X1O2PlusCyA - X19O2NoCyA
Glycerolipid metabolism,44,0.423144676,1,0.125435151,1.00E+00,0.120225516,0.927500267,0.092584198,1,X1O2PlusCyA - X19O2NoCyA
Fanconi anemia pathway,53,0.450430084,1,0.250291884,1.00E+00,0.059253538,0.785684535,0.131265041,1,X1O2PlusCyA - X19O2NoCyA
Endocrine and other factor-regulated calcium reabsorption,36,0.011640346,1,1,1.00E+00,0.626158156,1,0.997182149,1,X1O2PlusCyA - X19O2NoCyA
Bile secretion,34,0.02856558,1,0.473431279,1.00E+00,0.550050872,1,0.107126583,1,X1O2PlusCyA - X19O2NoCyA
PPAR signaling pathway,49,0.410384151,1,0.027787462,6.28E-01,0.664824993,1,0.109731196,1,X1O2PlusCyA - X19O2NoCyA
Amino sugar and nucleotide sugar metabolism,44,0.141562827,1,0.820136581,1.00E+00,0.066896402,0.785684535,0.246273426,1,X1O2PlusCyA - X19O2NoCyA
Protein export,23,0.136303003,1,0.326109279,1.00E+00,0.185026943,0.934467112,0.087358737,1,X1O2PlusCyA - X19O2NoCyA
Human T-cell leukemia virus 1 infection,192,0.149074252,1,0.409778067,1.00E+00,0.148892212,0.929509721,0.109110459,1,X1O2PlusCyA - X19O2NoCyA
MAPK signaling pathway,205,0.054475662,1,0.603809532,1.00E+00,0.281796399,0.976324898,0.135160387,1,X1O2PlusCyA - X19O2NoCyA
Mineral absorption,35,0.085064204,1,1,1.00E+00,0.109234496,0.913839805,0.99709593,1,X1O2PlusCyA - X19O2NoCyA
mTOR signaling pathway,131,0.152720048,1,0.629764027,1.00E+00,0.096640093,0.831919439,0.169079925,1,X1O2PlusCyA - X19O2NoCyA
Biosynthesis of unsaturated fatty acids,22,1,1,0.715134658,1.00E+00,0.013204331,0.531064654,0.999885407,1,X1O2PlusCyA - X19O2NoCyA
Adrenergic signaling in cardiomyocytes,93,0.05811579,1,0.995261273,1.00E+00,0.170916701,0.934467112,0.613761065,1,X1O2PlusCyA - X19O2NoCyA
Apoptosis,118,0.046865079,1,0.344035904,1.00E+00,0.625691112,1,0.108208853,1,X1O2PlusCyA - X19O2NoCyA
ABC transporters,29,0.232039637,1,0.462547915,1.00E+00,0.097016844,0.831919439,0.148873346,1,X1O2PlusCyA - X19O2NoCyA
Lipid and atherosclerosis,159,0.907385399,1,0.05432971,8.02E-01,0.225474593,0.934467112,0.321399064,1,X1O2PlusCyA - X19O2NoCyA
Epstein-Barr virus infection,176,0.817636578,1,0.756752284,1.00E+00,0.01835762,0.531064654,0.595463333,1,X1O2PlusCyA - X19O2NoCyA
Autophagy - other,30,0.02356414,1,0.760535197,1.00E+00,0.636311342,1,0.239695356,1,X1O2PlusCyA - X19O2NoCyA
Progesterone-mediated oocyte maturation,81,0.030502123,1,0.479012727,1.00E+00,0.934077305,1,0.247619666,1,X1O2PlusCyA - X19O2NoCyA
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,25,1,1,0.015287364,4.71E-01,0.914442504,1,0.999504257,1,X1O2PlusCyA - X19O2NoCyA
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,15,NA,NA,1,1.00E+00,0.052681677,0.785684535,0.999998304,1,X1O2PlusCyA - X19O2NoCyA
Axon guidance,121,0.019707341,1,0.976670162,1.00E+00,0.817114491,1,0.614122115,1,X1O2PlusCyA - X19O2NoCyA
Prion disease,222,0.019707341,1,0.856764361,1.00E+00,0.959478482,1,0.505547298,1,X1O2PlusCyA - X19O2NoCyA
"Glycine, serine and threonine metabolism",29,1,1,0.054436736,8.02E-01,0.310123799,0.984530065,0.99834933,1,X1O2PlusCyA - X19O2NoCyA
Sphingolipid signaling pathway,99,0.265161794,1,0.896977953,1.00E+00,0.072977893,0.785684535,0.440345806,1,X1O2PlusCyA - X19O2NoCyA
Melanoma,46,0.348928127,1,0.833673539,1.00E+00,0.062168398,0.785684535,0.414022676,1,X1O2PlusCyA - X19O2NoCyA
Relaxin signaling pathway,88,0.133019276,1,0.914860106,1.00E+00,0.154981378,0.929509721,0.409221759,1,X1O2PlusCyA - X19O2NoCyA
Estrogen signaling pathway,84,0.22177358,1,0.804145269,1.00E+00,0.112522327,0.918932338,0.339695142,1,X1O2PlusCyA - X19O2NoCyA
Cell cycle,118,0.369814297,1,0.452508369,1.00E+00,0.125762322,0.927500267,0.230550169,1,X1O2PlusCyA - X19O2NoCyA
Endometrial cancer,52,0.143703022,1,0.431798116,1.00E+00,0.348724162,1,0.168841961,1,X1O2PlusCyA - X19O2NoCyA
B cell receptor signaling pathway,74,0.275804901,1,0.998445474,1.00E+00,0.079611124,0.785684535,0.838406049,1,X1O2PlusCyA - X19O2NoCyA
Carbohydrate digestion and absorption,30,0.547424725,1,0.663341077,1.00E+00,0.061765647,0.785684535,0.404678927,1,X1O2PlusCyA - X19O2NoCyA
Leishmaniasis,59,0.488392398,1,0.207483658,1.00E+00,0.221717864,0.934467112,0.199407865,1,X1O2PlusCyA - X19O2NoCyA
Hippo signaling pathway - multiple species,21,0.733555144,1,0.462547915,1.00E+00,0.068757893,0.785684535,0.411278679,1,X1O2PlusCyA - X19O2NoCyA
Small cell lung cancer,75,0.611711601,1,0.519837161,1.00E+00,0.073883614,0.785684535,0.367243591,1,X1O2PlusCyA - X19O2NoCyA
Carbon metabolism,99,0.473057856,1,0.103173533,9.87E-01,0.483922738,1,0.189267567,1,X1O2PlusCyA - X19O2NoCyA
Mannose type O-glycan biosynthesis,19,NA,NA,0.248473282,1.00E+00,0.319157277,0.986224738,0.204955057,1,X1O2PlusCyA - X19O2NoCyA
Hematopoietic cell lineage,53,0.133019276,1,0.589999968,1.00E+00,0.310956738,0.984530065,0.22026207,1,X1O2PlusCyA - X19O2NoCyA
beta-Alanine metabolism,23,1,1,0.395036257,1.00E+00,0.06531817,0.785684535,0.999681386,1,X1O2PlusCyA - X19O2NoCyA
Autophagy - animal,124,0.067839855,1,0.534207606,1.00E+00,0.71339859,1,0.240269613,1,X1O2PlusCyA - X19O2NoCyA
Biosynthesis of cofactors,111,0.968312721,1,0.347382708,1.00E+00,0.076917908,0.785684535,0.660184912,1,X1O2PlusCyA - X19O2NoCyA
TNF signaling pathway,84,0.58177829,1,0.552390441,1.00E+00,0.082462517,0.785684535,0.376761782,1,X1O2PlusCyA - X19O2NoCyA
Fatty acid degradation,35,1,1,0.027797773,6.28E-01,0.955446735,1,0.999829469,1,X1O2PlusCyA - X19O2NoCyA
Viral carcinogenesis,179,0.759527441,1,0.903692141,1.00E+00,0.039785501,0.785684535,0.736634723,1,X1O2PlusCyA - X19O2NoCyA
Peroxisome,70,0.733555144,1,0.047439189,8.02E-01,0.787979466,1,0.356408707,1,X1O2PlusCyA - X19O2NoCyA
Pathways of neurodegeneration - multiple diseases,380,0.029702898,1,0.954193792,1.00E+00,0.998628815,1,0.844580413,1,X1O2PlusCyA - X19O2NoCyA
Lysosome,115,0.488392398,1,0.275978507,1.00E+00,0.212335707,0.934467112,0.237947934,1,X1O2PlusCyA - X19O2NoCyA
Breast cancer,107,0.271657465,1,0.599299489,1.00E+00,0.178209573,0.934467112,0.277494945,1,X1O2PlusCyA - X19O2NoCyA
Signaling pathways regulating pluripotency of stem cells,99,0.265161794,1,0.519837161,1.00E+00,0.212919202,0.934467112,0.246420478,1,X1O2PlusCyA - X19O2NoCyA
Human cytomegalovirus infection,169,0.199695557,1,0.913961253,1.00E+00,0.165558906,0.934467112,0.484104023,1,X1O2PlusCyA - X19O2NoCyA
Pertussis,51,0.085064204,1,0.426898021,1.00E+00,0.842534424,1,0.263711332,1,X1O2PlusCyA - X19O2NoCyA
Steroid hormone biosynthesis,19,NA,NA,0.760572879,1.00E+00,0.130859725,0.927500267,0.514609243,1,X1O2PlusCyA - X19O2NoCyA
Gastric cancer,105,0.310460983,1,0.441039099,1.00E+00,0.237229657,0.934467112,0.243199801,1,X1O2PlusCyA - X19O2NoCyA
Steroid biosynthesis,19,1,1,0.036683984,6.85E-01,0.935418401,1,0.999835844,1,X1O2PlusCyA - X19O2NoCyA
Butanoate metabolism,17,0.547424725,1,0.077670625,8.78E-01,0.82878783,1,0.315932212,1,X1O2PlusCyA - X19O2NoCyA
Inflammatory bowel disease,41,0.423144676,1,0.103533764,9.87E-01,0.805746485,1,0.269472066,1,X1O2PlusCyA - X19O2NoCyA
Ascorbate and aldarate metabolism,7,NA,NA,0.462547915,1.00E+00,0.236403388,0.934467112,0.327416928,1,X1O2PlusCyA - X19O2NoCyA
Non-homologous end-joining,13,0.054634655,1,1,1.00E+00,0.657220508,1,0.999397676,1,X1O2PlusCyA - X19O2NoCyA
Pathways in cancer,364,0.34585544,1,0.766378455,1.00E+00,0.136496767,0.927500267,0.41683157,1,X1O2PlusCyA - X19O2NoCyA
Proximal tubule bicarbonate reclamation,16,0.410384151,1,0.629457867,1.00E+00,0.140612285,0.927500267,0.363558343,1,X1O2PlusCyA - X19O2NoCyA
Diabetic cardiomyopathy,159,0.089733617,1,0.455334174,1.00E+00,0.900940631,1,0.323749278,1,X1O2PlusCyA - X19O2NoCyA
IL-17 signaling pathway,60,0.414875606,1,0.435576082,1.00E+00,0.20512647,0.934467112,0.286555479,1,X1O2PlusCyA - X19O2NoCyA
Pancreatic cancer,69,0.985799988,1,0.86919429,1.00E+00,0.044221764,0.785684535,0.934450611,1,X1O2PlusCyA - X19O2NoCyA
Cardiac muscle contraction,49,0.136303003,1,0.307652244,1.00E+00,0.922747699,1,0.309519324,1,X1O2PlusCyA - X19O2NoCyA
Transcriptional misregulation in cancer,126,0.637514848,1,0.297792469,1.00E+00,0.205225014,0.934467112,0.333192513,1,X1O2PlusCyA - X19O2NoCyA
Hippo signaling pathway,118,0.141028831,1,0.54919043,1.00E+00,0.521604328,1,0.272902921,1,X1O2PlusCyA - X19O2NoCyA
Non-small cell lung cancer,62,0.58177829,1,0.86201045,1.00E+00,0.080641783,0.785684535,0.619200624,1,X1O2PlusCyA - X19O2NoCyA
N-Glycan biosynthesis,47,0.410384151,1,0.771192143,1.00E+00,0.128771325,0.927500267,0.45930679,1,X1O2PlusCyA - X19O2NoCyA
Glycosphingolipid biosynthesis - globo and isoglobo series,11,NA,NA,0.154428288,1.00E+00,0.796011807,1,0.325192373,1,X1O2PlusCyA - X19O2NoCyA
JAK-STAT signaling pathway,86,0.473057856,1,0.477536069,1.00E+00,0.183361699,0.934467112,0.334120805,1,X1O2PlusCyA - X19O2NoCyA
Gap junction,63,0.086908831,1,0.91828441,1.00E+00,0.525315163,1,0.515159594,1,X1O2PlusCyA - X19O2NoCyA
Viral myocarditis,51,0.414875606,1,0.207483658,1.00E+00,0.498838433,1,0.25093445,1,X1O2PlusCyA - X19O2NoCyA
Complement and coagulation cascades,36,1,1,0.07596827,8.78E-01,0.582033599,1,0.99954924,1,X1O2PlusCyA - X19O2NoCyA
AMPK signaling pathway,97,0.987465062,1,0.79303961,1.00E+00,0.057366617,0.785684535,0.918017407,1,X1O2PlusCyA - X19O2NoCyA
Dopaminergic synapse,93,0.161978102,1,0.937637154,1.00E+00,0.301382982,0.984530065,0.559639308,1,X1O2PlusCyA - X19O2NoCyA
Cocaine addiction,32,0.231596118,1,0.800324217,1.00E+00,0.247919846,0.934467112,0.422358964,1,X1O2PlusCyA - X19O2NoCyA
Basal cell carcinoma,43,0.587279116,1,0.395036257,1.00E+00,0.199325053,0.934467112,0.361888981,1,X1O2PlusCyA - X19O2NoCyA
Riboflavin metabolism,7,NA,NA,0.575704195,1.00E+00,0.236403388,0.934467112,0.419967177,1,X1O2PlusCyA - X19O2NoCyA
Thyroid hormone synthesis,50,0.348928127,1,0.98063031,1.00E+00,0.139686161,0.927500267,0.748997921,1,X1O2PlusCyA - X19O2NoCyA
Pantothenate and CoA biosynthesis,16,1,1,0.07596827,8.78E-01,0.635067533,1,0.999627982,1,X1O2PlusCyA - X19O2NoCyA
Glycerophospholipid metabolism,66,0.420059495,1,0.144098557,1.00E+00,0.803803238,1,0.311125893,1,X1O2PlusCyA - X19O2NoCyA
Glioma,59,0.254874416,1,0.943811196,1.00E+00,0.20512647,0.934467112,0.6109556,1,X1O2PlusCyA - X19O2NoCyA
Various types of N-glycan biosynthesis,34,0.410384151,1,0.533532503,1.00E+00,0.226430499,0.934467112,0.35086136,1,X1O2PlusCyA - X19O2NoCyA
cGMP-PKG signaling pathway,110,0.180036865,1,0.918390322,1.00E+00,0.310828277,0.984530065,0.545990385,1,X1O2PlusCyA - X19O2NoCyA
FoxO signaling pathway,107,0.525217958,1,0.513068704,1.00E+00,0.193443298,0.934467112,0.39337725,1,X1O2PlusCyA - X19O2NoCyA
Pentose phosphate pathway,26,0.27695851,1,0.949011311,1.00E+00,0.201256606,0.934467112,0.637463354,1,X1O2PlusCyA - X19O2NoCyA
Human papillomavirus infection,248,0.623616455,1,0.944073091,1.00E+00,0.092931457,0.831919439,0.767188758,1,X1O2PlusCyA - X19O2NoCyA
Prolactin signaling pathway,52,0.133019276,1,0.907113339,1.00E+00,0.498838433,1,0.551375764,1,X1O2PlusCyA - X19O2NoCyA
Fat digestion and absorption,21,NA,NA,0.2202301,1.00E+00,0.764758104,1,0.38384203,1,X1O2PlusCyA - X19O2NoCyA
Focal adhesion,139,0.192229665,1,0.831873025,1.00E+00,0.379156759,1,0.474437764,1,X1O2PlusCyA - X19O2NoCyA
Citrate cycle (TCA cycle),29,0.547424725,1,0.116656378,9.89E-01,0.950955037,1,0.476527306,1,X1O2PlusCyA - X19O2NoCyA
Asthma,19,0.231596118,1,0.317532627,1.00E+00,0.82878783,1,0.335956128,1,X1O2PlusCyA - X19O2NoCyA
Cysteine and methionine metabolism,42,0.843293616,1,0.113602742,9.87E-01,0.642548143,1,0.506877358,1,X1O2PlusCyA - X19O2NoCyA
Huntington disease,255,0.06339252,1,0.97942706,1.00E+00,0.992803228,1,0.897589295,1,X1O2PlusCyA - X19O2NoCyA
Sulfur relay system,8,1,1,0.068893474,8.78E-01,0.896341845,1,0.999888815,1,X1O2PlusCyA - X19O2NoCyA
RNA polymerase,31,0.085064204,1,0.749125129,1.00E+00,0.977567049,1,0.621562789,1,X1O2PlusCyA - X19O2NoCyA
GnRH signaling pathway,74,0.086908831,1,0.882429078,1.00E+00,0.813552993,1,0.58811468,1,X1O2PlusCyA - X19O2NoCyA
VEGF signaling pathway,48,0.161978102,1,0.901971746,1.00E+00,0.433971307,1,0.551338524,1,X1O2PlusCyA - X19O2NoCyA
T cell receptor signaling pathway,79,0.125119267,1,0.54919043,1.00E+00,0.934077305,1,0.462918288,1,X1O2PlusCyA - X19O2NoCyA
Colorectal cancer,77,0.265161794,1,0.479012727,1.00E+00,0.514901392,1,0.333168776,1,X1O2PlusCyA - X19O2NoCyA
Aldosterone synthesis and secretion,62,0.355396903,1,0.764001039,1.00E+00,0.246011414,0.934467112,0.483813854,1,X1O2PlusCyA - X19O2NoCyA
Intestinal immune network for IgA production,35,0.843293616,1,0.253566337,1.00E+00,0.318544848,0.986224738,0.519280935,1,X1O2PlusCyA - X19O2NoCyA
Oocyte meiosis,108,0.13422244,1,0.625097575,1.00E+00,0.823574929,1,0.436233522,1,X1O2PlusCyA - X19O2NoCyA
Viral protein interaction with cytokine and cytokine receptor,30,0.410384151,1,0.551476557,1.00E+00,0.310123799,0.984530065,0.399232086,1,X1O2PlusCyA - X19O2NoCyA
Retinol metabolism,19,NA,NA,0.363964594,1.00E+00,0.52080178,1,0.392574325,1,X1O2PlusCyA - X19O2NoCyA
Rheumatoid arthritis,63,0.652700927,1,0.571649885,1.00E+00,0.189914447,0.934467112,0.514527685,1,X1O2PlusCyA - X19O2NoCyA
Renal cell carcinoma,56,0.194328722,1,0.900410945,1.00E+00,0.405124491,1,0.569959633,1,X1O2PlusCyA - X19O2NoCyA
Hepatitis C,116,0.496226774,1,0.789077756,1.00E+00,0.184605028,0.934467112,0.567352243,1,X1O2PlusCyA - X19O2NoCyA
Chronic myeloid leukemia,69,0.687378174,1,0.886475959,1.00E+00,0.11974795,0.927500267,0.742721337,1,X1O2PlusCyA - X19O2NoCyA
PI3K-Akt signaling pathway,223,0.502567749,1,0.719164954,1.00E+00,0.202389235,0.934467112,0.524033483,1,X1O2PlusCyA - X19O2NoCyA
Long-term potentiation,52,0.081478424,1,0.953632335,1.00E+00,0.950176123,1,0.791446328,1,X1O2PlusCyA - X19O2NoCyA
Fc epsilon RI signaling pathway,53,0.355396903,1,0.940255122,1.00E+00,0.221717864,0.934467112,0.681876244,1,X1O2PlusCyA - X19O2NoCyA
Measles,110,0.818349087,1,0.331949217,1.00E+00,0.276462373,0.97006671,0.533947821,1,X1O2PlusCyA - X19O2NoCyA
Primary immunodeficiency,28,0.714209374,1,0.839385231,1.00E+00,0.128384431,0.927500267,0.71848383,1,X1O2PlusCyA - X19O2NoCyA
EGFR tyrosine kinase inhibitor resistance,58,0.356913887,1,0.435576082,1.00E+00,0.495647717,1,0.363182863,1,X1O2PlusCyA - X19O2NoCyA
Neurotrophin signaling pathway,100,0.16597374,1,0.605528205,1.00E+00,0.784061319,1,0.4366579,1,X1O2PlusCyA - X19O2NoCyA
Rap1 signaling pathway,145,0.125119267,1,0.953850099,1.00E+00,0.665333773,1,0.692902628,1,X1O2PlusCyA - X19O2NoCyA
Osteoclast differentiation,98,0.724054443,1,0.479141461,1.00E+00,0.23085315,0.934467112,0.528918443,1,X1O2PlusCyA - X19O2NoCyA
Circadian rhythm,23,0.27695851,1,0.317532627,1.00E+00,0.957323644,1,0.486580094,1,X1O2PlusCyA - X19O2NoCyA
Hepatitis B,134,0.586652752,1,0.532697436,1.00E+00,0.27160773,0.97006671,0.485108225,1,X1O2PlusCyA - X19O2NoCyA
Cholesterol metabolism,33,0.733555144,1,0.125435151,1.00E+00,0.923076158,1,0.584067081,1,X1O2PlusCyA - X19O2NoCyA
Spinocerebellar ataxia,121,0.088517972,1,0.989264593,1.00E+00,0.978053379,1,0.916937836,1,X1O2PlusCyA - X19O2NoCyA
HIF-1 signaling pathway,88,0.697876454,1,0.297792469,1.00E+00,0.413172161,1,0.464364069,1,X1O2PlusCyA - X19O2NoCyA
Phagosome,119,0.403793749,1,0.367699702,1.00E+00,0.588270451,1,0.384672417,1,X1O2PlusCyA - X19O2NoCyA
"Alanine, aspartate and glutamate metabolism",24,0.410384151,1,0.981877644,1.00E+00,0.221160278,0.934467112,0.82009706,1,X1O2PlusCyA - X19O2NoCyA
Proteasome,45,0.089759701,1,0.99876175,1.00E+00,0.995562594,1,0.981848175,1,X1O2PlusCyA - X19O2NoCyA
Oxytocin signaling pathway,110,0.125119267,1,0.981811505,1.00E+00,0.739632023,1,0.803116246,1,X1O2PlusCyA - X19O2NoCyA
African trypanosomiasis,20,1,1,0.111729727,9.87E-01,0.82878783,1,0.999909931,1,X1O2PlusCyA - X19O2NoCyA
Amphetamine addiction,48,0.182954934,1,0.627220231,1.00E+00,0.814919931,1,0.485318095,1,X1O2PlusCyA - X19O2NoCyA
Sulfur metabolism,8,NA,NA,0.760572879,1.00E+00,0.312868155,0.984530065,0.640695756,1,X1O2PlusCyA - X19O2NoCyA
Fluid shear stress and atherosclerosis,96,0.993651256,1,0.181660013,1.00E+00,0.531796933,1,0.858610373,1,X1O2PlusCyA - X19O2NoCyA
Caffeine metabolism,1,NA,NA,1,1.00E+00,0.246570263,0.934467112,0.999999849,1,X1O2PlusCyA - X19O2NoCyA
Propanoate metabolism,32,0.795637237,1,0.16994781,1.00E+00,0.739705858,1,0.567171368,1,X1O2PlusCyA - X19O2NoCyA
2-Oxocarboxylic acid metabolism,17,NA,NA,0.253566337,1.00E+00,0.989296764,1,0.726747865,1,X1O2PlusCyA - X19O2NoCyA
Phototransduction,14,NA,NA,0.259063114,1.00E+00,0.974910218,1,0.671149725,1,X1O2PlusCyA - X19O2NoCyA
Galactose metabolism,24,0.733555144,1,0.229440894,1.00E+00,0.606918825,1,0.512857141,1,X1O2PlusCyA - X19O2NoCyA
Vitamin digestion and absorption,12,1,1,0.111382443,9.87E-01,0.966674925,1,0.999977952,1,X1O2PlusCyA - X19O2NoCyA
Starch and sucrose metabolism,27,0.423144676,1,0.663341077,1.00E+00,0.383640128,1,0.513066682,1,X1O2PlusCyA - X19O2NoCyA
One carbon pool by folate,18,1,1,0.154011781,1.00E+00,0.726095958,1,0.999907913,1,X1O2PlusCyA - X19O2NoCyA
Pancreatic secretion,56,0.182954934,1,0.860561478,1.00E+00,0.71132625,1,0.627486249,1,X1O2PlusCyA - X19O2NoCyA
Chemical carcinogenesis - DNA adducts,20,1,1,0.551476557,1.00E+00,0.203172609,0.934467112,0.999958332,1,X1O2PlusCyA - X19O2NoCyA
Arginine and proline metabolism,35,0.232039637,1,0.732858608,1.00E+00,0.661451154,1,0.533498994,1,X1O2PlusCyA - X19O2NoCyA
C-type lectin receptor signaling pathway,82,0.356913887,1,0.86919429,1.00E+00,0.363404449,1,0.638385879,1,X1O2PlusCyA - X19O2NoCyA
MicroRNAs in cancer,141,0.75254117,1,0.281950549,1.00E+00,0.535601256,1,0.542627552,1,X1O2PlusCyA - X19O2NoCyA
Insulin resistance,88,0.839725418,1,0.938374553,1.00E+00,0.144362867,0.929509721,0.893184445,1,X1O2PlusCyA - X19O2NoCyA
Ubiquinone and other terpenoid-quinone biosynthesis,10,NA,NA,1,1.00E+00,0.277161917,0.97006671,0.999999883,1,X1O2PlusCyA - X19O2NoCyA
Phenylalanine metabolism,11,NA,NA,1,1.00E+00,0.277161917,0.97006671,0.999999883,1,X1O2PlusCyA - X19O2NoCyA
Glycosaminoglycan biosynthesis - keratan sulfate,11,NA,NA,1,1.00E+00,0.277161917,0.97006671,0.999999883,1,X1O2PlusCyA - X19O2NoCyA
Ovarian steroidogenesis,24,0.232039637,1,0.923875954,1.00E+00,0.562774893,1,0.695231526,1,X1O2PlusCyA - X19O2NoCyA
Fatty acid metabolism,50,1,1,0.186422961,1.00E+00,0.656997729,1,0.999910621,1,X1O2PlusCyA - X19O2NoCyA
Cushing syndrome,110,0.271657465,1,0.646919338,1.00E+00,0.6984599,1,0.518617698,1,X1O2PlusCyA - X19O2NoCyA
Leukocyte transendothelial migration,81,1,1,0.823727132,1.00E+00,0.150380906,0.929509721,0.999993946,1,X1O2PlusCyA - X19O2NoCyA
Amyotrophic lateral sclerosis,302,0.124815692,1,0.996026678,1.00E+00,0.999651495,1,0.988555262,1,X1O2PlusCyA - X19O2NoCyA
Natural killer cell mediated cytotoxicity,81,0.231900924,1,0.714041398,1.00E+00,0.755132699,1,0.560756562,1,X1O2PlusCyA - X19O2NoCyA
Endocrine resistance,83,0.22177358,1,0.882429078,1.00E+00,0.6419184,1,0.658668125,1,X1O2PlusCyA - X19O2NoCyA
Insulin secretion,49,0.587279116,1,0.949011311,1.00E+00,0.225417068,0.934467112,0.820252846,1,X1O2PlusCyA - X19O2NoCyA
Selenocompound metabolism,15,0.547424725,1,0.395036257,1.00E+00,0.582808313,1,0.494311324,1,X1O2PlusCyA - X19O2NoCyA
Chemical carcinogenesis - receptor activation,123,0.525217958,1,0.640576757,1.00E+00,0.375703842,1,0.5609099,1,X1O2PlusCyA - X19O2NoCyA
Choline metabolism in cancer,72,0.265161794,1,0.982984002,1.00E+00,0.49031261,1,0.830467584,1,X1O2PlusCyA - X19O2NoCyA
Pyruvate metabolism,38,0.843293616,1,0.27995896,1.00E+00,0.545134579,1,0.62775544,1,X1O2PlusCyA - X19O2NoCyA
Fc gamma R-mediated phagocytosis,77,0.231900924,1,0.99970228,1.00E+00,0.568466592,1,0.965341658,1,X1O2PlusCyA - X19O2NoCyA
Thyroid hormone signaling pathway,100,0.350935045,1,0.541554315,1.00E+00,0.702968002,1,0.508815264,1,X1O2PlusCyA - X19O2NoCyA
Th17 cell differentiation,89,0.755201393,1,0.253826624,1.00E+00,0.723376131,1,0.599110018,1,X1O2PlusCyA - X19O2NoCyA
Long-term depression,43,0.348928127,1,1,1.00E+00,0.398952738,1,0.999921144,1,X1O2PlusCyA - X19O2NoCyA
Lysine degradation,51,0.717837475,1,0.203097265,1.00E+00,0.957172014,1,0.691612022,1,X1O2PlusCyA - X19O2NoCyA
AGE-RAGE signaling pathway in diabetic complications,74,0.90792808,1,0.996626267,1.00E+00,0.156633115,0.929509721,0.987513876,1,X1O2PlusCyA - X19O2NoCyA
Tryptophan metabolism,26,1,1,0.473431279,1.00E+00,0.29987107,0.984530065,0.999956629,1,X1O2PlusCyA - X19O2NoCyA
Nicotinate and nicotinamide metabolism,27,0.32928406,1,0.473431279,1.00E+00,0.914442504,1,0.576977717,1,X1O2PlusCyA - X19O2NoCyA
"Neomycin, kanamycin and gentamicin biosynthesis",3,NA,NA,0.575704195,1.00E+00,0.572388679,1,0.601518599,1,X1O2PlusCyA - X19O2NoCyA
Ubiquitin mediated proteolysis,131,0.313634437,1,0.729607021,1.00E+00,0.635678606,1,0.584159889,1,X1O2PlusCyA - X19O2NoCyA
Metabolism of xenobiotics by cytochrome P450,28,1,1,0.317532627,1.00E+00,0.468343821,1,0.999936324,1,X1O2PlusCyA - X19O2NoCyA
"Growth hormone synthesis, secretion and action",88,0.356913887,1,0.976089771,1.00E+00,0.437353719,1,0.837491104,1,X1O2PlusCyA - X19O2NoCyA
Drug metabolism - cytochrome P450,25,1,1,0.462547915,1.00E+00,0.331717903,1,0.999959547,1,X1O2PlusCyA - X19O2NoCyA
GABAergic synapse,46,0.547424725,1,0.935442161,1.00E+00,0.305297861,0.984530065,0.807212908,1,X1O2PlusCyA - X19O2NoCyA
Chagas disease,69,0.733555144,1,0.900410945,1.00E+00,0.238643739,0.934467112,0.833725716,1,X1O2PlusCyA - X19O2NoCyA
Cortisol synthesis and secretion,39,0.423144676,1,0.79988948,1.00E+00,0.467744832,1,0.651035947,1,X1O2PlusCyA - X19O2NoCyA
Influenza A,128,0.393230408,1,0.794055164,1.00E+00,0.5186993,1,0.645583699,1,X1O2PlusCyA - X19O2NoCyA
Taurine and hypotaurine metabolism,5,NA,NA,1,1.00E+00,0.359950507,1,0.999999938,1,X1O2PlusCyA - X19O2NoCyA
Kaposi sarcoma-associated herpesvirus infection,150,0.499991297,1,0.556936987,1.00E+00,0.60449447,1,0.577330384,1,X1O2PlusCyA - X19O2NoCyA
Renin secretion,38,0.32928406,1,0.760535197,1.00E+00,0.694684462,1,0.64292488,1,X1O2PlusCyA - X19O2NoCyA
cAMP signaling pathway,124,0.313040015,1,0.94657427,1.00E+00,0.605892558,1,0.797117198,1,X1O2PlusCyA - X19O2NoCyA
Protein digestion and absorption,42,0.795637237,1,0.395036257,1.00E+00,0.576036859,1,0.670955699,1,X1O2PlusCyA - X19O2NoCyA
Ras signaling pathway,150,0.350935045,1,0.597361365,1.00E+00,0.864662827,1,0.630594849,1,X1O2PlusCyA - X19O2NoCyA
"Parathyroid hormone synthesis, secretion and action",78,0.631052783,1,0.657296861,1.00E+00,0.437105009,1,0.663312993,1,X1O2PlusCyA - X19O2NoCyA
Sphingolipid metabolism,38,0.547424725,1,0.540349257,1.00E+00,0.617502526,1,0.602205001,1,X1O2PlusCyA - X19O2NoCyA
Melanogenesis,69,0.237838421,1,0.959458782,1.00E+00,0.803803238,1,0.840093859,1,X1O2PlusCyA - X19O2NoCyA
Non-alcoholic fatty liver disease,130,0.793410464,1,0.277355836,1.00E+00,0.860308125,1,0.715469371,1,X1O2PlusCyA - X19O2NoCyA
Staphylococcus aureus infection,38,0.547424725,1,0.410612724,1.00E+00,0.842654146,1,0.624987411,1,X1O2PlusCyA - X19O2NoCyA
NF-kappa B signaling pathway,79,0.787926791,1,0.955929537,1.00E+00,0.251915182,0.939205514,0.915293609,1,X1O2PlusCyA - X19O2NoCyA
Mitophagy - animal,65,0.932374673,1,0.266478775,1.00E+00,0.764233008,1,0.80278194,1,X1O2PlusCyA - X19O2NoCyA
Calcium signaling pathway,129,0.310460983,1,0.861953277,1.00E+00,0.71339859,1,0.725802808,1,X1O2PlusCyA - X19O2NoCyA
Vibrio cholerae infection,44,1,1,0.695886329,1.00E+00,0.274683494,0.97006671,0.999990345,1,X1O2PlusCyA - X19O2NoCyA
ECM-receptor interaction,43,1,1,0.282230314,1.00E+00,0.683425918,1,0.999965536,1,X1O2PlusCyA - X19O2NoCyA
Cellular senescence,136,0.887384997,1,0.750034529,1.00E+00,0.290389393,0.984530065,0.846253723,1,X1O2PlusCyA - X19O2NoCyA
TGF-beta signaling pathway,72,0.929452381,1,0.657296861,1.00E+00,0.334118946,1,0.856081574,1,X1O2PlusCyA - X19O2NoCyA
Oxidative phosphorylation,108,0.652700927,1,0.321878884,1.00E+00,0.976562543,1,0.765013618,1,X1O2PlusCyA - X19O2NoCyA
Th1 and Th2 cell differentiation,75,0.528941519,1,0.478530298,1.00E+00,0.813552993,1,0.639019586,1,X1O2PlusCyA - X19O2NoCyA
Bladder cancer,33,0.587279116,1,0.839385231,1.00E+00,0.428473358,1,0.764060838,1,X1O2PlusCyA - X19O2NoCyA
"Valine, leucine and isoleucine biosynthesis",3,NA,NA,0.435278893,1.00E+00,1,1,0.999047248,1,X1O2PlusCyA - X19O2NoCyA
Glyoxylate and dicarboxylate metabolism,23,1,1,0.420250615,1.00E+00,0.516391577,1,0.999974986,1,X1O2PlusCyA - X19O2NoCyA
Cholinergic synapse,73,0.420059495,1,0.999760146,1.00E+00,0.518673242,1,0.984370062,1,X1O2PlusCyA - X19O2NoCyA
Phospholipase D signaling pathway,102,0.231900924,1,0.973890605,1.00E+00,0.965895345,1,0.930965821,1,X1O2PlusCyA - X19O2NoCyA
ErbB signaling pathway,67,0.314112115,1,0.74857321,1.00E+00,0.92819854,1,0.752074206,1,X1O2PlusCyA - X19O2NoCyA
Fatty acid elongation,21,1,1,0.897436359,1.00E+00,0.243994476,0.934467112,0.999998856,1,X1O2PlusCyA - X19O2NoCyA
Salivary secretion,55,0.27695851,1,0.907113339,1.00E+00,0.912573206,1,0.839879546,1,X1O2PlusCyA - X19O2NoCyA
alpha-Linolenic acid metabolism,11,NA,NA,0.575704195,1.00E+00,0.796011807,1,0.721155077,1,X1O2PlusCyA - X19O2NoCyA
Notch signaling pathway,52,0.975745213,1,0.833673539,1.00E+00,0.287374298,0.984530065,0.956043195,1,X1O2PlusCyA - X19O2NoCyA
Apelin signaling pathway,99,0.275804901,1,0.98661621,1.00E+00,0.866142886,1,0.929918221,1,X1O2PlusCyA - X19O2NoCyA
Drug metabolism - other enzymes,39,0.509698964,1,0.749125129,1.00E+00,0.617502526,1,0.714770665,1,X1O2PlusCyA - X19O2NoCyA
Neuroactive ligand-receptor interaction,108,0.795637237,1,0.410612724,1.00E+00,0.734798376,1,0.737769241,1,X1O2PlusCyA - X19O2NoCyA
NOD-like receptor signaling pathway,135,0.638040692,1,0.775575835,1.00E+00,0.495194788,1,0.763875458,1,X1O2PlusCyA - X19O2NoCyA
RIG-I-like receptor signaling pathway,47,0.896030651,1,0.34982849,1.00E+00,0.802969892,1,0.816801831,1,X1O2PlusCyA - X19O2NoCyA
Salmonella infection,227,0.389879023,1,0.998503727,1.00E+00,0.688937269,1,0.973478115,1,X1O2PlusCyA - X19O2NoCyA
Hedgehog signaling pathway,40,0.587279116,1,0.469953181,1.00E+00,0.982302445,1,0.817516929,1,X1O2PlusCyA - X19O2NoCyA
Glycosphingolipid biosynthesis - lacto and neolacto series,18,NA,NA,NA,NA,0.85797017,1,0.85797017,1,X1O2PlusCyA - X19O2NoCyA
Vasopressin-regulated water reabsorption,35,0.509698964,1,0.71215112,1.00E+00,0.769144151,1,0.746318925,1,X1O2PlusCyA - X19O2NoCyA
Thiamine metabolism,10,NA,NA,0.629457867,1.00E+00,0.835446648,1,0.7828895,1,X1O2PlusCyA - X19O2NoCyA
Prostate cancer,73,0.724054443,1,0.84980533,1.00E+00,0.463170284,1,0.847800129,1,X1O2PlusCyA - X19O2NoCyA
Insulin signaling pathway,114,0.937354759,1,0.3403811,1.00E+00,0.897635236,1,0.889940484,1,X1O2PlusCyA - X19O2NoCyA
Toll-like receptor signaling pathway,68,0.552562055,1,0.915607877,1.00E+00,0.575195393,1,0.853934968,1,X1O2PlusCyA - X19O2NoCyA
Wnt signaling pathway,122,0.662154007,1,0.479141461,1.00E+00,0.928773604,1,0.789653291,1,X1O2PlusCyA - X19O2NoCyA
Antifolate resistance,25,0.733555144,1,0.475425802,1.00E+00,0.856247621,1,0.78184979,1,X1O2PlusCyA - X19O2NoCyA
Gastric acid secretion,46,0.655379398,1,0.975248463,1.00E+00,0.46738192,1,0.934019352,1,X1O2PlusCyA - X19O2NoCyA
GnRH secretion,41,0.423144676,1,0.994264507,1.00E+00,0.713629091,1,0.958373435,1,X1O2PlusCyA - X19O2NoCyA
Necroptosis,125,0.393230408,1,0.84059415,1.00E+00,0.917897428,1,0.842716404,1,X1O2PlusCyA - X19O2NoCyA
Hepatocellular carcinoma,131,0.79206423,1,0.804559575,1.00E+00,0.476351476,1,0.857201239,1,X1O2PlusCyA - X19O2NoCyA
"Phenylalanine, tyrosine and tryptophan biosynthesis",3,NA,NA,1,1.00E+00,0.572388679,1,0.999999987,1,X1O2PlusCyA - X19O2NoCyA
Endocytosis,217,0.327276982,1,0.996490202,1.00E+00,0.982892283,1,0.988495252,1,X1O2PlusCyA - X19O2NoCyA
Glutathione metabolism,37,1,1,0.431798116,1.00E+00,0.754629371,1,0.999992347,1,X1O2PlusCyA - X19O2NoCyA
Fatty acid biosynthesis,16,1,1,0.34633958,1.00E+00,0.946945542,1,0.999997135,1,X1O2PlusCyA - X19O2NoCyA
Synaptic vesicle cycle,52,0.547424725,1,0.882429078,1.00E+00,0.684851307,1,0.849573794,1,X1O2PlusCyA - X19O2NoCyA
Chemokine signaling pathway,121,0.525217958,1,0.892627678,1.00E+00,0.742622022,1,0.863936814,1,X1O2PlusCyA - X19O2NoCyA
Ferroptosis,34,0.587279116,1,0.627220231,1.00E+00,0.955446735,1,0.843797471,1,X1O2PlusCyA - X19O2NoCyA
SNARE interactions in vesicular transport,33,0.509698964,1,0.805067887,1.00E+00,0.858904264,1,0.838580157,1,X1O2PlusCyA - X19O2NoCyA
Adherens junction,63,0.58177829,1,0.883908258,1.00E+00,0.688382772,1,0.864456574,1,X1O2PlusCyA - X19O2NoCyA
Nitrogen metabolism,8,NA,NA,1,1.00E+00,0.62448511,1,0.999999991,1,X1O2PlusCyA - X19O2NoCyA
Longevity regulating pathway,73,0.730998548,1,0.971127242,1.00E+00,0.518673242,1,0.950965248,1,X1O2PlusCyA - X19O2NoCyA
Thyroid cancer,30,0.90792808,1,0.949011311,1.00E+00,0.428473358,1,0.968798045,1,X1O2PlusCyA - X19O2NoCyA
Hypertrophic cardiomyopathy,48,1,1,0.79988948,1.00E+00,0.466977176,1,0.999998599,1,X1O2PlusCyA - X19O2NoCyA
Collecting duct acid secretion,18,1,1,0.800324217,1.00E+00,0.467737437,1,0.999998611,1,X1O2PlusCyA - X19O2NoCyA
Porphyrin and chlorophyll metabolism,19,1,1,0.897436359,1.00E+00,0.418813198,1,0.999999555,1,X1O2PlusCyA - X19O2NoCyA
Homologous recombination,41,0.853899928,1,0.476689536,1.00E+00,0.93333186,1,0.890786386,1,X1O2PlusCyA - X19O2NoCyA
Phosphatidylinositol signaling system,84,0.757555814,1,0.54919043,1.00E+00,0.920369198,1,0.86000327,1,X1O2PlusCyA - X19O2NoCyA
Pathogenic Escherichia coli infection,162,0.454226982,1,0.978311627,1.00E+00,0.8634227,1,0.951415558,1,X1O2PlusCyA - X19O2NoCyA
Parkinson disease,211,0.441336806,1,0.879764072,1.00E+00,0.992797871,1,0.946099561,1,X1O2PlusCyA - X19O2NoCyA
Thermogenesis,190,0.858169418,1,0.45583679,1.00E+00,0.991672472,1,0.939788675,1,X1O2PlusCyA - X19O2NoCyA
Regulation of actin cytoskeleton,159,0.406315056,1,0.998364927,1.00E+00,0.985348937,1,0.995261111,1,X1O2PlusCyA - X19O2NoCyA
Arrhythmogenic right ventricular cardiomyopathy,40,1,1,0.420250615,1.00E+00,0.952766388,1,0.999998592,1,X1O2PlusCyA - X19O2NoCyA
Glucagon signaling pathway,85,0.880697879,1,0.587651886,1.00E+00,0.773929971,1,0.886101274,1,X1O2PlusCyA - X19O2NoCyA
Yersinia infection,114,0.418819051,1,0.987965691,1.00E+00,0.979586696,1,0.982944022,1,X1O2PlusCyA - X19O2NoCyA
mRNA surveillance pathway,83,0.472827596,1,0.999996214,1.00E+00,0.85967888,1,0.999478468,1,X1O2PlusCyA - X19O2NoCyA
Olfactory transduction,30,1,1,0.469953181,1.00E+00,0.877134793,1,0.999997544,1,X1O2PlusCyA - X19O2NoCyA
Spliceosome,133,0.412603663,1,0.999970385,1.00E+00,0.999999928,1,0.999996424,1,X1O2PlusCyA - X19O2NoCyA
Renin-angiotensin system,10,1,1,0.551476557,1.00E+00,0.748421233,1,0.999996794,1,X1O2PlusCyA - X19O2NoCyA
D-Glutamine and D-glutamate metabolism,4,NA,NA,1,1.00E+00,0.677883588,1,0.999999994,1,X1O2PlusCyA - X19O2NoCyA
Arginine biosynthesis,17,NA,NA,0.898604789,1.00E+00,0.754890599,1,0.92611165,1,X1O2PlusCyA - X19O2NoCyA
PD-L1 expression and PD-1 checkpoint pathway in cancer,78,0.717837475,1,0.996195874,1.00E+00,0.593587367,1,0.986189086,1,X1O2PlusCyA - X19O2NoCyA
Proteoglycans in cancer,149,0.856348993,1,0.561142698,1.00E+00,0.886961174,1,0.89684363,1,X1O2PlusCyA - X19O2NoCyA
Circadian entrainment,60,0.509698964,1,0.984870146,1.00E+00,0.849355737,1,0.965722872,1,X1O2PlusCyA - X19O2NoCyA
Inositol phosphate metabolism,67,0.793410464,1,0.560338285,1.00E+00,0.971351439,1,0.91423437,1,X1O2PlusCyA - X19O2NoCyA
Herpes simplex virus 1 infection,433,0.839373918,1,0.748177385,1.00E+00,0.687767448,1,0.898523409,1,X1O2PlusCyA - X19O2NoCyA
Systemic lupus erythematosus,96,0.795637237,1,0.615813601,1.00E+00,0.88924101,1,0.885657104,1,X1O2PlusCyA - X19O2NoCyA
Glycosaminoglycan biosynthesis - heparan sulfate / heparin,14,NA,NA,1,1.00E+00,0.709203007,1,0.999999996,1,X1O2PlusCyA - X19O2NoCyA
Glutamatergic synapse,74,0.509698964,1,0.959458782,1.00E+00,0.945224555,1,0.961244585,1,X1O2PlusCyA - X19O2NoCyA
Adipocytokine signaling pathway,54,1,1,0.571649885,1.00E+00,0.812707489,1,0.999998169,1,X1O2PlusCyA - X19O2NoCyA
Human immunodeficiency virus 1 infection,175,0.70914565,1,0.794375925,1.00E+00,0.832807659,1,0.897361952,1,X1O2PlusCyA - X19O2NoCyA
Amoebiasis,59,1,1,0.838698859,1.00E+00,0.561831339,1,0.99999945,1,X1O2PlusCyA - X19O2NoCyA
Aldosterone-regulated sodium reabsorption,27,0.733555144,1,0.897436359,1.00E+00,0.723115545,1,0.927836135,1,X1O2PlusCyA - X19O2NoCyA
Vascular smooth muscle contraction,81,0.58177829,1,0.995730708,1.00E+00,0.822657003,1,0.986097547,1,X1O2PlusCyA - X19O2NoCyA
Longevity regulating pathway - multiple species,48,0.985799988,1,0.97369099,1.00E+00,0.500618643,1,0.996493411,1,X1O2PlusCyA - X19O2NoCyA
Alcoholism,140,0.717837475,1,0.97818211,1.00E+00,0.726019769,1,0.972554563,1,X1O2PlusCyA - X19O2NoCyA
Morphine addiction,46,0.652700927,1,0.975846124,1.00E+00,0.814919931,1,0.970293293,1,X1O2PlusCyA - X19O2NoCyA
Pyrimidine metabolism,45,0.587279116,1,0.932125375,1.00E+00,0.951096899,1,0.960044729,1,X1O2PlusCyA - X19O2NoCyA
Nicotine addiction,12,NA,NA,NA,NA,0.974910218,1,0.974910218,1,X1O2PlusCyA - X19O2NoCyA
Dilated cardiomyopathy,51,1,1,0.833673539,1.00E+00,0.664824993,1,0.999999654,1,X1O2PlusCyA - X19O2NoCyA
Inflammatory mediator regulation of TRP channels,64,0.90792808,1,0.943811196,1.00E+00,0.670009806,1,0.980833939,1,X1O2PlusCyA - X19O2NoCyA
Mismatch repair,23,0.655379398,1,0.886725159,1.00E+00,0.990203477,1,0.974208753,1,X1O2PlusCyA - X19O2NoCyA
Nucleotide excision repair,46,0.714209374,1,0.84395831,1.00E+00,0.958281598,1,0.954885916,1,X1O2PlusCyA - X19O2NoCyA
Type II diabetes mellitus,29,0.795637237,1,0.935442161,1.00E+00,0.785908657,1,0.966558646,1,X1O2PlusCyA - X19O2NoCyA
Ribosome biogenesis in eukaryotes,80,0.603951061,1,0.978114565,1.00E+00,0.99225412,1,0.99212706,1,X1O2PlusCyA - X19O2NoCyA
Retrograde endocannabinoid signaling,94,1,1,0.714041398,1.00E+00,0.859788519,1,0.999999635,1,X1O2PlusCyA - X19O2NoCyA
Shigellosis,215,0.714097834,1,0.983227443,1.00E+00,0.878670121,1,0.986139193,1,X1O2PlusCyA - X19O2NoCyA
Epithelial cell signaling in Helicobacter pylori infection,60,0.929452381,1,0.940255122,1.00E+00,0.727620142,1,0.986424296,1,X1O2PlusCyA - X19O2NoCyA
Cytosolic DNA-sensing pathway,41,0.655379398,1,0.990815347,1.00E+00,0.982302445,1,0.995393794,1,X1O2PlusCyA - X19O2NoCyA
Folate biosynthesis,15,1,1,0.69643547,1.00E+00,0.933044635,1,0.999999813,1,X1O2PlusCyA - X19O2NoCyA
Platelet activation,90,0.877910949,1,0.999767899,1.00E+00,0.742800709,1,0.999496013,1,X1O2PlusCyA - X19O2NoCyA
Pentose and glucuronate interconversions,13,NA,NA,1,1.00E+00,0.867851401,1,0.999999999,1,X1O2PlusCyA - X19O2NoCyA
Bacterial invasion of epithelial cells,64,0.717837475,1,0.992654743,1.00E+00,0.950251118,1,0.995299598,1,X1O2PlusCyA - X19O2NoCyA
Maturity onset diabetes of the young,9,1,1,1,1.00E+00,0.691565986,1,1,1,X1O2PlusCyA - X19O2NoCyA
Base excision repair,33,0.764390925,1,0.924120914,1.00E+00,0.996294293,1,0.992548011,1,X1O2PlusCyA - X19O2NoCyA
Purine metabolism,99,0.806756698,1,0.983515827,1.00E+00,0.888423407,1,0.992282233,1,X1O2PlusCyA - X19O2NoCyA
Tight junction,133,0.927574798,1,0.977863082,1.00E+00,0.837692289,1,0.995875281,1,X1O2PlusCyA - X19O2NoCyA
Acute myeloid leukemia,56,0.788645762,1,0.968702138,1.00E+00,0.997981172,1,0.997761586,1,X1O2PlusCyA - X19O2NoCyA
Serotonergic synapse,65,0.843293616,1,0.99286034,1.00E+00,0.916587354,1,0.997321651,1,X1O2PlusCyA - X19O2NoCyA
RNA degradation,73,0.84454327,1,0.997852211,1.00E+00,0.93205798,1,0.999010726,1,X1O2PlusCyA - X19O2NoCyA
Primary bile acid biosynthesis,9,NA,NA,1,1.00E+00,0.94121856,1,1,1,X1O2PlusCyA - X19O2NoCyA
Basal transcription factors,42,0.871690326,1,0.990815347,1.00E+00,0.922481571,1,0.997621106,1,X1O2PlusCyA - X19O2NoCyA
Arachidonic acid metabolism,25,1,1,0.820177871,1.00E+00,0.972108601,1,0.999999981,1,X1O2PlusCyA - X19O2NoCyA
Neutrophil extracellular trap formation,138,0.952768946,1,0.996067711,1.00E+00,0.844982886,1,0.999344634,1,X1O2PlusCyA - X19O2NoCyA
Regulation of lipolysis in adipocytes,33,1,1,1,1.00E+00,0.812949961,1,1,1,X1O2PlusCyA - X19O2NoCyA
Ether lipid metabolism,27,1,1,0.864961424,1.00E+00,0.972108601,1,0.999999991,1,X1O2PlusCyA - X19O2NoCyA
DNA replication,36,0.968312721,1,0.986178072,1.00E+00,0.944269275,1,0.999444094,1,X1O2PlusCyA - X19O2NoCyA
RNA transport,162,0.94466125,1,0.999658137,1.00E+00,0.990528198,1,0.99998376,1,X1O2PlusCyA - X19O2NoCyA
Taste transduction,34,1,1,1,1.00E+00,0.946828461,1,1,1,X1O2PlusCyA - X19O2NoCyA
Phosphonate and phosphinate metabolism,5,1,1,1,1.00E+00,1,1,1,1,X1O2PlusCyA - X19O2NoCyA
Linoleic acid metabolism,9,NA,NA,NA,NA,1,1,1,1,X1O2PlusCyA - X19O2NoCyA
Biotin metabolism,3,NA,NA,NA,NA,1,1,1,1,X1O2PlusCyA - X19O2NoCyA
